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Abstract 
Verbal fluency tests are one of the most commonly used measures of 
executive functioning in neuropsychological testing and play an important 
role in the assessment, diagnosis and care planning of patients with a 
variety of conditions, including brain tumour. There is little conclusive 
evidence about which factors may influence verbal fluency outcomes. No 
studies to date have investigated the interactions between a comprehensive 
range of demographic variables, mood scores, tumour factors and key 
cognitive skills with the focus of verbal fluency outcomes in brain tumour 
patients. Similarly, clarification is required across studies assessing the 
localisation effects of verbal fluency skills. To address these gaps in the 
evidence base this study used a retrospective cohort design of cross-
sectional data from patients with brain tumours, to investigate their 
performance of both phonemic and semantic verbal fluency. More 
specifically this study used simple linear and multiple regression calculations 
to analyse the interactions between these variables and other potentially 
important factors such as localisation, depression and anxiety (using the 
HADS), age, gender, education, premorbid functioning (using the TOPF), 
semantic memory (using the GNT), and tumour type.  
The results showed that an increase in phonemic fluency 
performance was significantly correlated with being educated, an increase in 
semantic memory, and an increase in premorbid functioning. Phonemic 
fluency was also significantly correlated with localisation. In general, a 
decrease in phonemic fluency was significantly associated with tumours in 
the left frontal lobe. An increase in semantic fluency was correlated with an 
increase in semantic memory. No other factors showed significant 
associations with phonemic or semantic fluency. The outcomes from the 
hierarchical multiple regressions indicated that localisation, gender, 
education, tumour type, depression, semantic memory, and premorbid 
functioning when combined can predict phonemic fluency variance. 
Combining localisation effects, semantic memory, depression and education 
together do not result in a model that predicts semantic fluency, as within 
this model the only significant relationship was between semantic memory 
and semantic fluency. These findings show that, for brain tumour patients, it 
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is important to take into consideration tumour localisation, education, 
semantic memory, and premorbid functioning when assessing and care 
planning for deteriorations in phonemic fluency. Similar patients with 
deteriorations in semantic fluency need to have their results considered in 
light of performance in semantic memory tests.  
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Introduction 
Verbal fluency is a particularly specialised area of research within the 
larger field of cognitive functioning. This study aimed to build upon previous 
research in this area by investigating relationships between verbal fluency 
outcomes and tumour variables (localisation and tumour type), mood factors 
(depression and anxiety), cognitive factors (premorbid functioning and 
semantic memory), and demographic factors (education and gender).  
The following introduction will begin by providing background 
information on brain tumours and their symptoms, with a particular focus on 
cognitive abilities, psychological wellbeing, and what it is about tumours that 
can lead to these outcomes. The literature review will initially focus on 
research within the broader area of cognitive functioning in the brain tumour 
population, with the aim of better understanding the gaps in the research 
base relating to verbal fluency. This review will then focus in on the evidence 
base behind the relationships between mood, localisation effects and verbal 
fluency skills, which will form the foundations of the research questions for 
this project. These questions are operationalised throughout the method 
section.   
What is a brain tumour 
A brain tumour is a collection of abnormal growths of tissue 
(neoplasm) that arise in the brain or structures closely related to the 
functioning of the brain, such as the meninges. Brain tumours account for 
the majority of central nervous system (CNS) tumours. If they start in the 
brain they are called primary brain tumours.  If they spread into the brain 
from somewhere else in the body they are called secondary brain tumours. 
Due to a variety of tumours being classified as “brain tumour” but situated in 
areas other than the brain itself, it has been suggested that the term brain 
tumour can be misleading, and the terminology “intracranial neoplasm” is 
more fitting (DeAngelis, 2001). The World Health Organization makes more 
sense of this by grouping together these (and related other) tumours under 
the category of “Tumours of the Central Nervous System” (Louis et al., 2007, 
2016). However, a vast majority of research in this area, and the majority of 
services, charities, and organisations within the community who support 
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these patients still separate brain tumours from other central nervous system 
tumours and therefore, use the terminology “brain tumour” (Cancer 
Research UK). In line with this, this study will continue to use the 
terminology brain tumour more generally, and will focus more specifically 
upon certain types of brain tumour relevant to this research.  
Classifying brain tumours 
The intricacies of tumour classification have been refined and 
updated in line with scientific developments over the years (Kleihues et al., 
2002; Louis et al., 2007, 2016). The most commonly used classification 
systems are those developed by the World Health Organization, the most 
recent of which was published in 2016 (Louis et al., 2016). It is important to 
note that there are always exceptions to classifications of tumour, especially 
with brain tumours, as there are many grey areas in the classification criteria 
used, and variations in how the tumour behaves and develops within each 
classification (Yang et al., 2008). 
Tumour grading and malignancy 
Tumours are graded between 1 and 4 depending on how quickly they 
are likely to grow. These can be more largely separated into ‘high-grade’ and 
‘low-grade’ tumours, relating respectively to whether the tumour grows 
rapidly and is aggressive, or develops more slowly (Louis et al., 2007; NICE, 
2006). Low grade tumours (grades 1 and 2) are generally regarded as 
benign and high-grade tumours (grades 3 and 4) are commonly regarded as 
malignant. Benign tumours are relatively slow growing and unlikely to spread 
to other areas. As a result they may only require surgery as a treatment 
option (not radiotherapy or chemotherapy as well), and are less likely to 
return following resection. Malignant tumours are comparatively faster 
growing and more likely to spread to other parts of the brain or spinal cord. 
They tend to require treatments such as radiotherapy or chemotherapy as 
well as surgery, and even with these treatments they are more likely to re-
occur post-treatment.  
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Tumour type and origin 
There are about 130 different types of brain tumour (Louis et al., 
2007). Most brain tumours are generally named after the type of cell they 
developed from and/or the area of the brain they are growing in, for 
example, tumours within the meninges (the membranes that surround and 
protect the brain) are referred to as a meningioma. The main types of tumour 
relevant to this study are glioma and meningioma.  
Within the tumours that occur in the brain and CNS in adults, the 
cerebrum is the most common origin (Louis et al., 2016). Secondary to this, 
around a quarter (24%) of brain and CNS tumours start in the meninges, and 
around 10% start in the glands within the brain, such as the pituitary and 
pineal gland. In children the picture is significantly different, with about 60% 
of childhood brain tumours originating in the cerebellum or brain stem 
(Wefel, Vardy, Ahles, & Schagen, 2011).  
Aetiology of brain tumour 
The aetiology of brain tumours is largely unknown and there is little 
evidence that they can be prevented by lifestyle changes (NICE, 2006). The 
risks of developing a brain tumour are dependent on age and gender, with 
trends of diagnoses showing an inverse social gradient, being more common 
in more affluent groups and developed countries (Quinn & Babb, 2000). 
However, it could be argued that this perception is strongly biased by 
inaccurate report rates as opposed to being indicative of actual prevalence 
rates (NICE, 2006).This is largely due to the bias in reporting created by 
developed countries being more likely to  provide healthcare systems able to 
fund expensive scanning technologies (e.g. CT head scanners) and a 
structured means to record and report said diagnoses. Similarly, people from 
affluent groups are likely to reside in countries with this access to services, 
as well as having greater access to healthcare education, further enhancing 
the likelihood that they would present to services when experiencing 
symptoms. These factors are more likely to increase reporting rates as 
opposed to increase the prevalence of the condition within the population. 
 
- 18 - 
Prognosis of patients with brain tumour 
Tumours cause risk for a number of factors as they grow, firstly they 
can increase intracranial pressure which can cause severe (and sometimes 
fatal) symptoms (NICE, 2006). Additionally, they weave into adjacent normal 
brain tissue in a manner which can make surgical removal very difficult 
(NICE, 2006). A brain tumour can therefore rarely be completely removed 
because of its relation to critical functional structures within the brain and the 
infiltrating nature of the tumour. These difficulties generally lead to a poor 
prognosis for the condition (NICE, 2006).  
It can take several years to collect data and compile statistical 
reports. Cancer Research UK have compiled the latest review (for 2014) 
from a range of sources reporting across the UK such as the Office for 
National Statistics, and the National Cancer Intelligence Unit (Cancer 
Research UK). From this data they believe that in 2014 alone 10,981 new 
cases of CNS and intracranial tumour were reported in the UK, which is 3% 
of the total cancer cases reported that year (Cancer Research UK). This 
consisted of 5,288 (48%) males and 5,693 (52%) females. These statistics 
also indicate a 30% increase in brain tumour incidence rates since the early 
1990’s, consisting of 2881 (55%) males and 2342 (45%) females (Cancer 
Research UK). This increase resulted in 5,223 deaths in 2014, nearly half of 
whom (47%) were in people aged 70+ (Cancer Research UK). 
Of equal importance, changes in cognitive function can have 
prognostic significance in patients with brain tumours (Taphoorn & Klein, 
2004), for example, tumour patients’ performance on verbal memory tasks 
have been linked to survival rates (Meyers, Hess, Yung, & Levin, 2000). 
Therefore, having an awareness of changes in a patient’s cognitive 
functioning can have implications for their ability to plan for and receive 
appropriate care. 
Diagnosis and treatment plans 
It has been shown that cognitive deterioration can indicate tumour 
progression before signs of tumour recurrence are evident on CT or MRI 
scans (Armstrong, Goldstein, Shera, Ledakis, & Tallent, 2003; Meyers & 
Hess, 2003). However, a wide range of symptoms have been associated 
- 19 - 
with a diagnosis of brain tumour, including headache, nausea, vomiting, 
seizure, memory loss, limb pain, loss of sensation, weakness, visual 
difficulty, and change in behaviour or personality (NICE, 2006). When 
symptoms of a possible brain tumour are raised as a concern, the patient is 
sent for a CT or MRI scan, and the diagnosis is confirmed through a biopsy 
(NICE, 2006). A confirmed diagnosis will often lead to care support through 
a specific neuroscience brain and other CNS tumour multidisciplinary team 
(MDT), with an important aspect of this support being a focus on maximizing 
their quality of life (NICE, 2006). Many patients (and/or their relatives/carers) 
will also access psychological support from specific members of the MDT.  
There are a wide variety of tumour classifications and a variety of 
treatment approaches can be recommended in relation to these, such as 
resection (surgical removal of as much of the tumour as possible), 
radiotherapy, chemotherapy, or a combination of these. Intracranial pressure 
and related symptoms (such as one sided weakness) can often be reduced 
using steroids (NICE, 2006). Consultants will consider the grade of the 
tumour, whether it is malignant or benign, the tumour type and its 
origin/location to decide upon the best treatment pathway. Therefore, the 
diagnostic classification of the tumour is instrumental in attempting to predict 
treatment and prognosis for each individual. 
The effects of brain tumour 
There are a wide variety of physical, cognitive and psychological 
symptoms associated with the impact of a brain tumour, which can be 
influenced by its anatomical location (Jenkins, Drummond, & Andrewes, 
2016; Lynam et al., 2007; Meyers, Berman, Scheibel, & Hayman, 1992; 
Meyers et al., 2000; Weitzner & Meyers, 1997). Patients may experience 
epilepsy,  headache, social dysfunction, cognitive deficit, behavioural, 
emotional and personality changes (Gregor et al., 1996; Jenkins et al., 2016; 
Meyers et al., 1992; Taphoorn & Klein, 2004; van Breemen, Wilms, & Vecht, 
2007). These symptoms tend to be biologically linked to progressive focal 
neurological deficits and/or raised intracranial pressure. Raised intracranial 
pressure typically causes headaches which are worse in the morning, 
nausea, vomiting or visual deterioration. Gradual-onset weakness or sensory 
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loss on one side of the body is common, as is difficulty with speech or 
understanding, and unilateral visual field loss (NICE, 2006).  
The role of brain tumour patients in localisation studies 
Cognitive neuroscience utilises a wide range of techniques to 
investigate the neural architecture of the brain. These types of investigation 
are historically rooted in theories based on the assumption that discrete 
anatomical modules deal with different cognitive functions, referred to as a 
‘modularity assumption’ (Shallice, 1988). Some of the first cases 
demonstrating this method used single dissociation lesion-behaviour 
mapping in patients with neurological damage (e.g. the famous case 
described by Oliver Sacks of ‘the man who mistook his wife for a hat’; Sacks, 
2011). This traditional approach involved observing a specific behavioural 
deficit related to a subcomponent (function Y) of a complex cognitive task 
(despite intact functioning in another subcomponent of that skill; function X). 
The dissociation in functioning would either be observed following surgical 
removal of, or damage to a specific neural area. Otherwise the patient’s 
brain would be dissected after they had died to figure out which neural 
region had been damaged. This information would be used to imply that 
damage to this specific region impacts the behavioural subcomponent of 
interest (function Y).  
By advancing the approach of single dissociation lesion-behaviour 
mapping to include two experimental manipulations (which each have 
different effects on two dependent variables) the ability to make specific 
inferences about brain function and function localisation is increased. This is 
referred to as a double dissociation (Teuber, 1955). More explicitly, drawing 
from the example above, this would involve comparing two patients with 
brain lesions in different areas demonstrating opposing deficits from the 
subcomponents analysed (i.e. patient 1 having a deficit in function Y but not 
X, and patient 2 having a deficit in function X but not Y). The main 
advantage of the lesion-behaviour mapping method is that it allows us to see 
that a certain neural region is necessary for a specific cognitive function, 
which is why this approach has made huge contributions to our 
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understanding of neuroanatomical functioning both historically and in the 
present era (Rorden & Karnath, 2004).  
However, there are methodological drawbacks to the above 
theoretical approaches, such as the restrictions imposed by making 
assumptions of modularity when it may often be the case that the cognitive 
functions of interest are carried out in a distributed manner, with larger 
regions of the brain working together in a more fluid/plastic state (Farah, 
1994). Similarly there are inferences that neural areas not obviously 
damaged in the observed lesion are functioning adequately (Farah, 1994). 
This can be problematic particularly in studies with brain tumour patients as 
there are often effects from other sources such as neural pressure caused 
by oedema that can impact functioning more broadly around the tumour 
location. Advancements in technologies (such as fMRI scanning) have 
allowed investigations of neural-behavioural associations in neurologically 
healthy individuals which can complement results found in lesion-behaviour 
mapping studies as they don’t suffer from the methodological issues of 
having to focus on a single, fixed neural-correlate location, or the additional 
complications created by illness and injury. However, there are significant 
limitations to interpreting brain activation studies (Sarter, Berntson, & 
Cacioppo, 1996). Primarily, while they provide evidence that a particular 
activation area correlates with the performance of a task they can’t infer that 
the area is actually necessary to perform the task, or whether the activation 
of that area is a ‘by-product’ to the activation of another area (Sarter et al., 
1996). Furthermore, the interpretation of regions where no change in 
activation is shown on the scans can be misleading because the fMRI 
scanner cannot detect the possible contributions of regions that are 
constantly active, regardless of the task (Rorden & Karnath, 2004). The fMRI 
approach (measuring activation) therefore has a poorer level of inference 
than the lesion method (measuring disruption) which allows us to infer that 
the neural correlate investigated is actually required for the task being 
measured (Rorden & Karnath, 2004; Sarter et al., 1996).  
In addition there are practical restrictions often imposed on 
researchers as the use of technologies such as fMRI scanners is costly and 
often not part of standard healthcare protocol, meaning that there are fewer 
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opportunities for researchers to use this approach, particularly when a vast 
majority of research is derived from poorly funded or voluntary sources. For 
these reasons lesion-behaviour mapping studies are still a popular approach 
to investigating the neural correlates of cognitive function and patients with 
brain tumour are an invaluable source of information in continuing to 
advance the evidence base in this arena. 
Anxiety and depression 
Mixed anxiety and depression is the most common mental health 
condition in Britain, with 7.8% of people meeting criteria for clinical diagnosis 
(NICE, 2011; Pilling, Whittington, Taylor, Kendrick, & Guideline Development 
Group, 2011). Those from poorer or disadvantaged backgrounds are more 
likely to be affected by common mental health problems and their 
consequences (Patel, Lund, Hatherill, Plagerson, Corrigall, Funk, 2010). In 
the most recent survey (undertaken 2014 to 2015) by the Office for National 
Statistics (ONS), as measured using the General Health Questionnaire 
(GHQ 12), 17.3% of individuals in the UK reported scores that indicate mild-
to-moderate levels of anxiety or depression (ONS, 2017). This is a positive 
reduction from the previous year’s score of 19.7%, however, it still indicates 
that nearly one in five adults experience these symptoms (ONS, 2017). The 
survey highlights that individuals living in the north-east (18.7%), people 
aged 16 to 24 (19.4%) and women (20.1%) are most likely to report 
difficulties with symptoms of anxiety or depression (ONS, 2017). These 
difficulties have been estimated to cause one fifth of days lost from work in 
Britain and so are not only significantly disabling the individuals concerned, 
but are associated with significant financial costs to the workforce and the 
National Health Services (Das-Munshi et al., 2008). 
Anxiety and depression in patients with brain tumour 
The impact of a diagnosis of brain tumour has been shown to be 
devastating for both the patient and the family (Wideheim, Edvardsson, 
Påhlson, & Ahlström, 2002). Prevalence rates of patients with intracranial 
brain tumours who experience psychological distress, such as anxiety and 
depression, vary significantly among reports from 16% (Pringle, Taylor, & 
Whittle, 1999), to more than double this at 42.7% (Zabora, Brintzenhofeszoc, 
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Curbow, Hooker, & Piantadosi, 2001). In comparison to other types of 
cancer patient, the severity of psychological distress in patients with brain 
tumour has been found to be second only to patients with lung cancer 
(Zabora et al., 2001). Additionally, the likelihood of anxiety and depression 
has been shown to be greater prior to surgery for tumour resection (Pringle 
et al., 1999) in meningioma patients in comparison to patients with other 
types of brain tumour (Pringle et al., 1999), and has been positively 
correlated with levels of physical disability and cognitive dysfunction 
(Anderson, Taylor, & Whittle, 1999). Psychological distress is therefore a 
present and important factor to consider in this population.  
Cognitive Functioning 
Cognitive function can be defined as cerebral processing that we use 
to perceive, understand, navigate and behave within our surroundings 
(Lezak, 1995). More specifically, discrete cognitive functions have been 
defined within the areas of motor skills, perception, attention, memory, 
language, visual and spatial processing. Executive functioning is seen as a 
higher-order form of cognitive processing that integrates and coordinates 
these more discreet skills (Lezak, 1995).  
Cognitive functioning in patients with brain tumour 
A number of systematic reviews have been conducted on the topic of 
cognitive functioning in patients with brain tumour, often focusing on one 
specific histological type, such as meningioma (Meskal, Gehring, Rutten, & 
Sitskoorn, 2016), or a histological tumour type specified further by its 
grading, for example, low grade glioma (van Loon et al., 2015), or high grade 
glioma (Weitzner & Meyers, 1997). Systematic reviews in this area tend to 
draw similar conclusions, highlighting that patients with brain tumour, to 
some extent, appear to experience deficits in a range of cognitive functions, 
most obviously prior to tumour resection, but also following resection 
(Meskal et al., 2016; van Loon et al., 2015; Weitzner & Meyers, 1997). 
However, they also conclude that the evidence base in this area is difficult to 
integrate and make sense of in a clinically meaningful or reliable way. This 
has been discussed as being due to a number of key reasons:- 
- 24 - 
• very few studies in this area have provided severity data (e.g. 
effect sizes, incidences) to allow the comparison and integration of 
outcomes 
• a majority of the studies have used relatively insensitive 
assessment measures, such as the MMSE and 3MS which are not sensitive 
enough to discriminate between mild cognitive impairment and normal 
cognitive functioning (Meyers & Hess, 2003) 
• the assessment measures used have been too varied across 
the evidence base to allow for valid and reliable comparison of results 
• the definitions of what constitutes cognitive dysfunction have 
been too varied across the evidence base to allow for valid and reliable 
comparison of results 
• many studies have failed to consider important mitigating 
factors that impact the assessment of cognitive functioning, such as 
premorbid functioning, mood, location of the tumour, size of the tumour, 
types of treatment received prior to testing, and the time of measurement 
(Habets et al., 2014; Meskal et al., 2016; van Loon et al., 2015; Weitzner & 
Meyers, 1997). 
These difficulties in making sense of the evidence base mean that the 
results found cannot be interpreted with confidence by either practitioners or 
academics. However, these results do provide a general view that patients 
with brain tumours are impaired to some extent in many areas of cognitive 
functioning (Meskal et al., 2016; van Loon et al., 2015; Weitzner & Meyers, 
1997). 
Executive functioning 
Executive functioning has been hypothesised to represent an 
individual’s ability to integrate a range of cognitive functions (such as 
memory and language) while promoting cognitive flexibility and problem 
solving skills (Della Sala, Gray, Spinnler, & Trivelli, 1998). The range of 
functions covered by this concept is vast, however, mental set shifting, 
information updating and monitoring, and inhibition of dominant responses 
have been commonly linked to some of the key tests used to assess 
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executive functioning (Fisk & Sharp, 2004; Miyake et al., 2000). These core 
executive functioning skills are moderately correlated with one another, but 
clearly separable functions in their contributions to common executive 
functioning assessments (Miyake et al., 2000). 
Executive functioning in patients with brain tumour 
Deficits in executive functioning are commonly found in patients with 
brain tumours, as measured directly (Davidson et al., 2008) and through 
observer ratings of functional difficulties associated with executive 
functioning, such as issues of impulsivity and inflexibility (Jenkins et al., 
2016). Studies investigating executive functioning have similar 
methodological difficulties to studies investigating cognitive functioning 
(discussed above), in terms of there being too much variability in decisions 
about the definition of executive functioning and the best way of measuring it 
(Alvarez & Emory, 2006). In terms of measurement, there are many different 
tests of executive functioning, as well as complete batteries, which test a 
wide range of different executive functions such, as the Delis-Kaplan 
Executive Function System (Delis, Kaplan, & Kramer, 2001b).  
Verbal fluency 
Verbal fluency tests require the co-ordination of a range of cognitive 
skills and functions, meeting the criteria of commonly used definitions for 
executive functioning (Miyake et al., 2000; Stuss & Levine, 2002). These 
tests are one of the most commonly used measures of executive functioning 
in neuropsychological testing, as they are quick, easy to administer, and do 
not rely upon examinee motor skills which often impede test outcomes for 
many people with neurocognitive difficulties. Verbal fluency outcomes play 
an important role in the diagnosis of a number of conditions within the 
clinical population, such as attention deficit/hyperactivity disorder (Andreou & 
Trott, 2013), Alzheimer’s disease (Mathuranath, Nestor, & Berrios, 2010; 
Monsch et al., 1992; Zhao, Guo, & Hong, 2013), and Parkinson’s disease 
(Pettit, McCarthy, Davenport, & Abrahams, 2013). Verbal fluency tests 
therefore play a highly instrumental role in neuropsychological assessment 
and diagnosis. This means that advancing the knowledge base in this area 
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is important to ensure the provision of accurate and reliable 
neuropsychological assessment and care of patients. 
Verbal fluency tests can be semantic (sometimes described as 
category fluency), which would involve generating names that belong to a 
certain category (e.g. animals or fruits), or phonemic, which would involve 
generating words that begin with a certain letter of the alphabet. Phonemic 
and semantic fluency tests are similar in the sense that they both require a 
number of information processing demands including retrieval fluency and 
figuring out strategies to search the lexicon. They also both involve language 
abilities, oral-motor processing, and selective attentional processes (such as 
self-monitoring answers already given), using effortful control perseveration, 
self-initiation and inhibition of responses where appropriate to prevent errors 
(McCloskey & Perkins, 2012). However, there are some key differences in 
the skills and processes required for each of these forms of verbal fluency 
test (McCloskey & Perkins, 2012). 
Phonemic verbal fluency 
In addition to the skills highlighted above, phonemic fluency requires 
the generation of non-habitual strategies based primarily on lexical 
representations, meaning the individual needs to have a level of phonemic 
awareness to be able to complete this task (McCloskey & Perkins, 2012). 
Utilising this kind of orthographic criteria is quite unusual in relation to 
everyday functions, making it a more valid test of organic executive 
functioning as opposed to a learned and practised skill. In line with this, it 
has been suggested that phonemic fluency is a more accurate measure of 
executive functioning than semantic fluency, due to the novelty of the 
strategies required to complete phonemic fluency tests and the reliance of 
semantic fluency on semantic memory, as opposed to executive dysfunction 
(Ardila, Ostrosky‐Solís, & Bernal, 2006; Henry & Crawford, 2004).  
One of the most common tests to measure phonemic verbal fluency is 
the FAS test, but some tests use other letters, such as C, F and L (Benton et 
al., 1994; Spreen & Strauss, 1998). Slight differences in letter difficulty and 
word fluency have been described in some studies for each letter (e.g. 
Barry, Bates, & Labouvie, 2008). This indicates that separate norms should 
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be used for each version of this test (Strauss, Sherman, Spreen, & Spreen, 
2006). However, correlations between letter sets are generally quite high 
(e.g. .83 between FAS and BHR in the DKEFS) demonstrating that this test 
holds its validity between different forms (Delis, Kaplan, & Kramer, 2001a).  
The FAS test is formally included as a subtest in a variety of 
neuropsychological batteries, including the Neurosensory Centre 
Comprehensive Examination for Aphasia (NCCEA; Spreen & Benton, 1977), 
and the Delis-Kaplan Executive Function System (D-KEFS; Delis et al., 
2001a). It can also be used on its own as various norms, and meta norms 
are readily available in a number of studies (Gladsjo et al., 1999; Loonstra, 
Tarlow, & Sellers, 2001; Rodriguez-Aranda & Martinussen, 2006; Strauss et 
al., 2006). The internal consistency has been found to be high in this test (r = 
.83), and test-retest reliability is moderately high .74 (Tombaugh, Kozak, & 
Rees, 1999).  
Semantic verbal fluency 
Semantic fluency tests are thought to rely heavily on processes 
involved in the concept of ‘clustering’ where the participant will be required to 
find groups of related words within a certain category. For example, under 
the category of ‘animals’ an individual might consider selecting clusters such 
as ‘pets’, ‘woodland creatures’, or ‘safari animals’. Semantic fluency tasks 
therefore rely heavily on the participant having an intact semantic memory 
organisation/network. The skill of switching between clusters when the 
participant has run out of ideas within a cluster also plays an important role 
in semantic fluency performance.  
The most common semantic fluency test is the Animal Naming Test 
(ANT), used in larger neurocognitive batteries such as the D-KEFS (Delis et 
al., 2001b). The ANT can also be used on its own, with norms being readily 
available in a number of studies (Gladsjo et al., 1999; Tombaugh et al., 
1999). The internal consistency of the ANT has been measured by age 
groups divided roughly into decades (Delis et al., 2001a). For the adult age 
groups (aged 16-89) the internal consistency ranges between 0.60 (group 
16-19 years) and 0.76 (groups 30-39 and 80-89 years) (Delis et al., 2001a). 
The test-retest reliability coefficient measured for all ages was 0.79 (Delis et 
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al., 2001a). Using the category ‘animal’ has significant advantages to other 
categories because it is a clear enough semantic category to use with 
different languages and different cultures, and it is considered to be a 
relatively easy semantic category with only minor differences in performance 
across people of different educational systems or generations (Ardila et al., 
2006).  
Verbal fluency in patients with brain tumour 
Only seven studies have been conducted that compare healthy 
controls to tumour patients pre-surgery in measures of semantic and 
phonemic fluency, with the few that meet this criteria focusing on a wider 
range of neurocognitive impairments, as opposed to focusing more 
specifically on verbal fluency outcomes (Hoffermann et al., 2017; Klein et al., 
2001; Miotto et al., 2011; Påhlson, Ek, Ahlström, & Smits, 2003; Talacchi et 
al., 2011; Tucha, Smely, & Lange, 2001; Tucha et al., 2003). Miotto et al., 
(2011) conducted the only study found demonstrating deficits in both 
semantic and phonemic fluency (using the ANT and the FAS test 
respectively) in pre-surgery glioma patients (both low and high grade). Due 
to a low sample size (N: 27) they were unable to complete any statistical 
analyses, so these outcomes are based on counting the number of patient 
deficits, most likely compared to the norms of the test (although this method 
is not confirmed in the paper). When including studies using resected tumour 
patients, statistically significant differences have been found in both 
semantic and phonemic fluency (also using the ANT and the FAS test) with 
patients with mixed tumour types of grades 1-2 (Goldstein, Obrzut, John, 
Hunter, & Armstrong, 2004) and grades 2-4 (Davidson et al., 2008) 
compared to healthy controls.  
Phonemic fluency differences (in comparison to healthy controls) 
have been reported in patients who have non-resected meningioma (Tucha, 
Smely, & Lange, 2001; Tucha et al., 2003), glioma (Påhlson et al., 2003; 
Talacchi et al., 2011) and mixed tumour type (Hoffermann et al., 2017). 
However, only two of these studies (Hoffermann et al., 2017; Oliver Tucha et 
al., 2003) were able conduct statistical analyses and report significant 
differences due to sample size limitations. Semantic fluency has been even 
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less frequently studied, with only one study reporting statistically significant 
differences between healthy controls and high and low grade glioma patients 
(Klein et al., 2001). A similar study looking at patients with resected tumours 
has also demonstrated significant differences in semantic fluency between 
healthy controls and low grade meningioma patients (van Nieuwenhuizen et 
al., 2007).  
It is clear that there is a limited range of studies available in this area, 
with this range further reduced by a large percentage of the studies not 
having sample sizes large enough to complete statistical analyses. However, 
among these studies there is a consistent consensus of deficits in both 
phonemic and semantic fluency being present in the brain tumour 
population. It is therefore important that these deficits are comprehensively 
understood to ensure appropriate care and treatment for patients with brain 
tumour diagnoses. 
Factors influencing verbal fluency 
Age, gender, and education are the most commonly evaluated 
demographic variables within neurocognitive research, and studies in 
phonemic and semantic fluency are no exception. Of equal relevance to this 
study, education, premorbid functioning and semantic memory will also be 
reviewed in terms of their associations with verbal fluency outcomes.  
Demographic factors: Age, gender and education 
Phonemic and semantic fluency both tend to improve during 
childhood, however, this increase is accelerated more within phonemic 
fluency (Delis et al., 2001a). This increase has been shown to peak when an 
individual reaches their thirties and shows a mild decline in old age (Delis et 
al., 2001a; Tombaugh et al., 1999). However, when considering the 
influence of ‘age of onset of condition’ of patients and the diversity of 
population norms within the brain tumour population (from non-clinical 
population norms), accounting for time related effects such as age can 
become more complex and less clinically meaningful. It may therefore be a 
less reliable trait of influence in this study.  
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Many studies have individually found little evidence of gender 
differences between phonemic and semantic fluency (e.g. Riva, Nichelli, & 
Devoti, 2000; Tombaugh et al., 1999). However, when a meta-analysis was 
conducted by Loonstra et al., (2001) the outcomes highlighted that women 
(M equals 35.14, SD equals 12.59) perform slightly better than men (M 
equals 33.28, SD equals 12.96) in letter fluency. This difference has not 
been replicated in semantic fluency (Delis et al., 2001a).  
Education has been consistently highly correlated with both phonemic 
and semantic fluency outcomes, with high levels of education being 
associated with better performance (Delis et al., 2001a; Gladsjo et al., 1999; 
Loonstra et al., 2001). 
Cognitive factors: IQ, semantic memory and premorbid 
functioning 
IQ shows an even stronger relationship to phonemic fluency than 
education and is often considered a more reliable and valid influencing 
variable to measure (Steinberg, Bieliauskas, Smith, & Ivnik, 2005). IQ is 
therefore an important factor to consider when evaluating specific cognitive 
functions. However, it is important to consider that current IQ is likely to vary 
as a result of neurological injury, and that this variability would need to be 
accounted for when considering the influence of various demographic 
variables with a specific cognitive function. Premorbid functioning refers to 
the cognitive and functional abilities of a person prior to the onset of injury or 
illness. Knowing an individual’s premorbid functioning is important because it 
allows for a more accurate measurement of any change in functioning that 
the individual has experienced, as opposed to making assumptions based 
on population norms. Premorbid functioning is therefore an important 
variable to consider in looking at cognitive outcomes in populations with 
neurological deficits (Crawford, Moore, & Cameron, 1992; Strauss et al., 
2006). In support of this, modest to high correlations (.27-.67) have been 
reported between premorbid functioning (as measured by the NART) and 
phonemic fluency (Bird, Papadopoulou, Ricciardelli, Rossor, & Cipolotti, 
2004; Crawford et al., 1992; Ross, 2003) and between phonemic fluency 
and the ‘word reading’ subtest of the WIAT-II (Davis et al., 2017). This 
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suggests that there is a premorbid relationship between phonemic fluency 
and word reading as measured by these tests (Bird et al., 2004; Crawford et 
al., 1992; Davis et al., 2017;Ross, 2003; Strauss et al., 2006).  
The Test of Premorbid Functioning (TOPF; Wechsler, 2011) is a 
similar reading test to the two tests used in the above studies (NART and 
WIAT-II). It has been shown to overcome criticisms of previous tests (such 
as the WTAR; Wechsler 2001) which revealed the estimates of functioning 
were lower than expected for people with neurodegenerative conditions such 
as dementia and brain injury. One of the design aims of the TOPF was to 
reduce the effect of brain injury and dementia on the predictive equations, to 
obtain a more accurate estimate of premorbid ability, particularly within 
populations who have neurodegenerative conditions (Wechsler, 2011). As a 
result of this increase in validity, the TOPF has become a primary part of 
common neurocognitive assessment batteries used in neuropsychology 
services today and therefore holds greater clinical utility within these 
services. As premorbid functioning has been highlighted as a more accurate 
predictor of phonemic fluency than the more commonly measured 
‘education’, and the TOPF is the test of premorbid functioning with the 
greatest clinical utility at this moment in time, it is important for correlations 
between the TOPF and phonemic fluency to be investigated. Unfortunately, 
such investigations have not been conducted and so need to be analysed to 
support the effectiveness of the design of future research and clinical 
considerations using these measurement factors.  
As described above verbal fluency tasks require a substantial verbal 
component, for example, phonemic fluency is highly correlated with general 
measures of verbal skills (see Henry & Crawford, 2004, for a review). 
Semantic memory is a more specific component of verbal language skills 
which focuses on an individual’s ability to process ideas and concepts from 
their long-term memory that are not drawn from personal experience. 
Semantic memory is often associated with ‘common knowledge’ and 
includes things such as names of colours, capital cities, and types of 
furniture. The Boston Naming Test (BNT; Goodglass, Kaplan, & Weintraub, 
1983) and the Graded Naming Test (GNT; Mckenna & Warrington, 1980) 
are tools commonly used to measure semantic memory by assessing an 
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individual’s ability to name common objects. Semantic memory (as assessed 
by the BNT) has been associated with both phonemic and semantic fluency 
in two studies, with semantic fluency showing stronger correlations (.57- .86) 
than phonemic fluency (.43 - .50) in both papers (Henry, Crawford, & 
Phillips, 2004; Riva et al., 2000). Due to a lack of studies in this area it is 
difficult to draw confident conclusions about relationships between semantic 
memory and verbal fluency outcomes, however, the papers discussed 
consistently highlight positive relationships between both semantic and 
phonemic fluency and semantic memory test outcomes.  
Tumour factors: type, size, speed of growth, grading 
As discussed above there are over 130 different types of tumour, 
which vary in histological factors such as type, grading and growth 
speed/size (Louis et al., 2007; NICE, 2006). The impact of these different 
factors on cognitive functioning in patients with brain tumour has been 
researched to some extent, the results of which will be described below. 
Due to there being no studies focusing more specifically on verbal 
fluency and tumour histology effects, this topic will be discussed in relation to 
the effects of tumour factors more generally on cognitive functioning.  
Type of tumour 
Very few studies have investigated the effects of tumour type on 
cognitive functioning. In fact only one study has explicitly set out to look at 
this relationship. Kayl and Meyers (2003) investigated the relationship 
between tumour histology and cognitive functioning in patients with 
glioblastoma multiforme and anaplastic astrocytoma. They found that the 
mean test scores in patients with anaplastic astrocytoma were superior on 
nearly all measures administered, in comparison to patients with 
glioblastoma multiforme, however, these differences were not statistically 
significant. They concluded that tumour histology was not a significant 
predictor of cognitive functioning after controlling for tumour volume (Kayl & 
Meyers, 2003). However, it is worth noting that these patients were 
assessed post-surgery, meaning that the tumours had been removed and 
the patients had started their recovery (Kayl & Meyers, 2003). It makes 
sense that tumour effects are going to be most obvious when the tumour is 
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still present and impacting upon patient’s performance, as opposed to 
measuring the effects of the remaining lesion. Additionally, this study did not 
appear to consider the effects of pre-morbid functioning or mood, which are 
important factors to consider when assessing any form of cognitive 
functioning.  
A small number of studies have analysed these relationships as part 
of a more general focus looking into different aspects of cognitive functioning 
in patients with brain tumour, finding no significant relationships between 
these specific factors (Hoffermann et al., 2017; Hom & Reitan, 1984; 
Scheibel, Meyers, & Levin, 1996). A study by Hahn et al., (2003) did show 
mixed results, in that there was a significant difference in neuropsychological 
functioning between patients with glioblastoma multiforme and patients with 
other types of tumour. Unfortunately the paper does not discuss what tumour 
types were included in the ‘other types of tumour’ group. More specifically 
they highlight that, when the tests were separately analysed, patients with 
glioblastoma multiforme performed significantly poorer than patients with 
other types of tumour on a visual scanning task to measure components of 
executive functioning (Trails A). They also found similar differences in 
phonemic fluency (as measured by the COWA test) between the patient 
groups, with the differences approaching significance (p = 0.056). However, 
no other significant effects were found despite testing a range of cognitive 
functions (Hahn et al., 2003). Interestingly, the two test outcomes described 
above which did show some difference (Trails A and COWA) are both forms 
of executive functioning measure, indicating that perhaps this is an area of 
cognitive functioning especially sensitive to the impact of tumour type. 
Although it is worth noting that other tests of executive functioning were 
assessed (such as Trails B and the Stroop Colour-Word Test) which showed 
no difference between the groups (Hahn et al., 2003). It is not clear within 
the paper whether the patients had received chemotherapy or other 
treatment related to their condition. The paper does discuss that some 
patients may have been in the early stages of receiving radiotherapy, which 
has been linked with changes in cognitive functioning (Correa, 2010; Douw 
et al., 2009) and so could have influenced results. These very few studies do 
point towards trends in differences between the effects of different tumour 
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types, more specifically indicating that glioblastoma multiforme tumours are 
more likely to impact certain tests of executive functioning (including 
phonemic fluency), but they do not provide statistically significant evidence 
or information on a wider range of tumour types. This is an area where more 
research is required. 
Tumour size/volume 
Kayl and Meyers, (2003) concluded that the lack of significant effects 
found in the above study were most strongly linked to the influence of 
tumour volume (Kayl & Meyers, 2003). More direct correlations were found 
by Talacchi, Santini, Savazzi, and Gerosa, (2011) who assessed  patients 
with various grades of glioma pre-operatively, finding that 79% of patients 
were impaired across a wide range of tests, and that these effects were 
related to larger tumour size (as well as higher tumour grade and the impact 
of oedema). This study has an impressively comprehensive methodology, 
ensuring that practice effects were controlled for in nearly all their 
assessments and assessing for both anxiety and depression. They limited 
their recruitment to glioma patients only, so these results are not 
representative of the brain tumour population more broadly, and they were 
only able to recruit 29 patients, which is likely to have limited the power and 
generalisability of their results.  
Very few studies have further investigated and reported on the impact 
of tumour volume, despite the correlations found above. The exceptions 
include two studies which found no significant relationships (Noll, Sullaway, 
Ziu, Weinberg, & Wefel, 2014; Oliver Tucha et al., 2003). Unlike the study 
above (Talacchi et al., 2011), the studies that have not found effects appear 
to be slightly less rigorous in the measures taken to account for confounding 
variables, such as mood (Noll et al., 2014) and premorbid functioning (Oliver 
Tucha et al., 2003). Additionally, Tucha et al., (2003) chose to categorise the 
tumours into two tumour volume groups (small and large), but did this by 
ranking the patients in order of tumour size, dividing the ranking into three 
groups (smallest, medium and largest), then comparing the bottom third 
(smallest) with the top third (largest) and ignoring the middle third. Creating a 
dichotomous variable from a range of scores in this way results in the loss of 
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a significant amount of the data relevant to the analysis, and so the 
outcomes were not representative of the population studied. In conclusion, 
there is some evidence that tumour size impacts cognitive functioning but 
that these results have not been replicated in proceeding studies. These 
discrepancies may be due to methodological flaws. This is therefore another 
area where further research is required.  
Tumour growth speed 
Hom & Reitan (1984) conducted one of the earliest studies on the 
effects of tumour growth speed on cognitive functioning in patients with brain 
tumour. While they did not classify the brain tumours by distinct type in line 
with the more developed classification systems used clinically today, they 
did use various forms of biological and technological examination to classify 
their 92 patients into four different grades of rapid to slow growing types of 
tumour. Each patient was given an extensive battery of psychological tests, 
which comprised of measures related to verbal and performance abilities, 
attention, speech – sounds perception, executive functioning and primary 
motor functioning. Their results highlighted that rapidly growing tumours 
were associated with greater performance deficits (Hom & Reitan, 1984). 
However, it is worth noting that their inclusion criteria were relatively broad, 
not taking into account different pathological characteristics of the tumour, 
most importantly tumour size. Similarly they did not match the patients by 
age, with the comparable groups varying significantly in this demographic. 
Each of these factors are quite important to consider when investigating 
cognitive functioning and could have been having an underlying effect in 
place of the growth speed effects found. 
Tumour grading 
Tumour grading has been slightly more extensively considered, 
particularly within glioma focused studies (Hom & Reitan, 1984; Kayl & 
Meyers, 2003; Miotto et al., 2011; Noll et al., 2014; Talacchi et al., 2011). It 
is often the case that speed of growth and tumour grading are considered 
synonymously, for example, the study above by Hom & Reitan (1984) was 
primarily focused on speed of growth of the tumour, however, the way they 
grouped their participants was by the expected growth speed of specific 
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grades of tumour (with rapid growth being associated with grade three or 
four, and slow growth being associated with grades one and two). While 
their study lacked validity by not considering age or tumour volume effects 
(as discussed above) they did find significant differences in cognitive 
performance between the two groups, with the lower grade tumour patients 
showing less cognitive deficit (Hom & Reitan, 1984).  
Kayl & Meyers, (2003) controlled for more variables by matching their 
participants on various demographics, including age and tumour volume, 
however, they focused on a narrow range of tumour types (grade four 
glioblastoma and grade three anaplastic astrocytoma). They did not find any 
significant results once controlling for tumour volume, but their sample only 
consisted of 48 participants. Considering that this small number of 
participants was used to account for a large number of variables, and the 
fact that they were unable to assess each patients tumour volume at the 
same time as their neurocognitive functioning, meaning their argument is 
relatively weak (Kayl & Meyers, 2003). 
Miotto et al., (2011) also compared cognitive functioning in a range of 
low grade and high grade glioma patients (including astrocytoma, 
oligodendroglioma, and multiforme glioblastomas), finding that patients with 
high grade glioma experienced significant impairment on a range of 
cognitive functions, particularly executive functioning and memory tests. It is 
worth considering that their sample size was quite small with only 19 low-
grade glioma patients and eight high grade glioma patients. Additionally, 
while they excluded patients if they had a history of psychosis or depression, 
there were no attempts to measure current mood in the sample, which has 
been shown in similar studies to influence the correlations found between 
tumour grading and cognitive functioning (Talacchi, Santini, Savazzi, and 
Gerosa, 2011). Nor were tumour volume or location considered.  
The study by Noll, Sullaway, Ziu, Weinberg, and Wefel, (2014) was 
designed with the aim of overcoming some of these methodological flaws, 
preoperatively assessing the impact of tumour grade in 72 left temporal lobe 
(grade two to four) tumour patients (including oligodendroglioma, 
astrocytoma, and mixed glioma). They found that processing speed, verbal 
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learning, executive functioning, and language abilities were more impaired in 
patients with grade four tumours compared to patients with lower grade 
tumours. They were able to improve upon a number of the methodological 
weaknesses discussed above by controlling for tumour volume, seizure 
status, and anti-epileptic or steroid use, with their results remaining 
significant (grade four tumour patients performing significantly lower than 
grades two and three) following this. 
While conclusions were drawn only based upon generic 
neurocognitive functioning, Noll et al., (2014) helpfully reported their 
outcomes for each individual test which included a measure of phonemic 
fluency (the MAE COWA test). This outcome highlighted that there was a 
significant difference between phonemic fluency scores in patients with 
grade four tumours in comparison to patients with grade two and three 
tumours (Noll et al., 2014). This outcome, supported by the wider evidence 
base indicating links between tumour grades and cognitive performance 
more generally, indicates that there may be a relationship between tumour 
grade and phonemic fluency performance in patients with brain tumour (Hom 
& Reitan, 1984; Miotto et al., 2011; Noll et al., 2014). 
Summary of the effects of tumour factors on cognitive 
functioning and verbal fluency 
It would be fair to conclude that there is a significant lack of research 
in this area, with the few studies available showing mixed results and being 
unable to rule out a number of methodological flaws which may have 
influenced the conclusions. Trends have been found indicating that tumour 
type (Hahn et al., 2003; Kayl & Meyers, 2003) and tumour size may be 
associated with some aspects of cognitive functioning more generally. 
However, only one study included a test of phonemic fluency and no studies 
looked into semantic fluency. Additionally the results supporting these trends 
were either not significant or have not been replicated in later studies factors 
(Hoffermann et al., 2017; Hom & Reitan, 1984; Scheibel et al., 1996). There 
were also methodological issues which may have impacted the validity of the 
results, most significantly in relation to the patients being assessed post-
surgery (Kayl & Meyers, 2003). Tumour growth speed has been shown to 
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impact cognitive functioning, however, this has only been investigated in one 
study (Hom & Reitan, 1984). These areas therefore require further 
investigation.  
The effects of tumour grading have been more readily reported and 
these results are slightly more consistent, indicating that higher graded 
tumours will have a greater impact on cognitive performance, with one study 
showing significant differences whilst confounding factors were controlled for 
(Noll et al., 2014). This study was also the only study to highlight a 
relationship between tumour factors and a test of verbal fluency more 
specifically, indicating that patients with grade four tumours are likely to 
score lower in phonemic fluency in comparison to patients with grade two 
and three tumours (Noll et al., 2014).  
Mood factors: depression and anxiety 
Depression 
The influence of depression on cognitive functioning has been 
historically reported (Blaney, 1986; Brown, Scott, Bench, & Dolan, 1994; 
Johnson & Magaro, 1987; Miller, 1975), and reviewed in a meta-analysis 
highlighting that not only does depression create deficits in the vast majority 
of cognitive functions, but it does so increasingly as the severity of 
depression increases (Christensen, Griffiths, MacKinnon, & Jacomb, 1997). 
Patients with depression present with poorer outcomes in a wide range of 
tests designed to capture executive dysfunction (Nathan, Wilkinson, 
Stammers, & Low, 2001). In comparing the deficits of executive functioning 
skills (such as verbal fluency), to differential cognitive deficits (such as 
psychomotor speed) it has been suggested that perhaps depression creates 
a generalised cognitive impairment, as opposed to a specific deficit in 
executive functioning (Henry & Crawford, 2005).  
In contrast to this, while some patients demonstrate deficits in a wide 
range of cognitive functions when depressed, it has been found that deficits 
in executive functioning are more strongly associated with depression than 
other cognitive functions (Kaiser et al., 2003; Veiel, 1997). More specifically, 
in some studies, tests of verbal fluency have been shown to be the most 
sensitive to changes in levels of depression, in comparison to other 
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executive or cognitive functioning tests (Brown et al., 1994; Talacchi et al., 
2011; Trichard et al., 1995).  
Further discrepancies about the effects of depression on each of the 
verbal fluency tests have arisen between study outcomes, with some studies 
showing that both semantic and phonemic fluency are equally affected by 
depression (Brown et al., 1994; Christensen et al., 1997; Trichard et al., 
1995; Yochim, Mueller, & Segal, 2013), others showing that semantic 
fluency is more impaired than phonemic fluency (Fossati, Amar, Raoux, 
Ergis, & Allilaire, 1999), and others showing that phonemic fluency is more 
impaired than semantic fluency in depressed patients (Beatty, Wonderlich, 
Staton, & Ternes, 1990). A thorough meta-analysis has attempted to resolve 
these discrepancies, showing that when the standard methodology adopted 
by other meta-analytic reviews was used to assess the performance of 
semantic and phonemic fluency in depressed patients, the outcome 
indicated that semantic fluency was most sensitive to the effects of 
depression (Henry & Crawford, 2005). However, when they applied a more 
rigorous method of meta-analysis the results showed that both phonemic 
and semantic fluency were similarly impaired by the presence of depression 
symptoms (Henry & Crawford, 2005). While there is not a large evidence 
base behind this topic area, the results from this meta-analysis appear 
relatively reliable and noteworthy (Henry & Crawford, 2005) and the majority 
of evidence suggests that depression negatively impacts executive 
functioning, including both phonemic and semantic verbal fluency 
performance (Beatty et al., 1990; Brown et al., 1994; Christensen et al., 
1997; Fossati et al., 1999; Kaiser et al., 2003; Nathan et al., 2001; Talacchi 
et al., 2011; Trichard et al., 1995; Veiel, 1997; Yochim et al., 2013). 
Anxiety 
The area of verbal fluency and anxiety has received comparatively 
little attention in previous research, with few studies in the area of executive 
functioning and anxiety in the adult population, fewer on the more specific 
area of anxiety and verbal fluency, and still fewer studies including semantic 
fluency alongside phonemic fluency in their outcomes (O’Shea et al., 2016). 
In the study described above by Talacchi et al. (2011), relationships were 
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found between depression and verbal fluency, however similar relationships 
between anxiety and cognitive functioning, executive functioning, or 
phonemic fluency were not. This suggests that these two types of 
psychological distress may have very different effects on functioning 
(Talacchi et al., 2011) and so it is important to consider them separately. In 
support of a lack of interactions between anxiety and verbal fluency, 
Smitherman, Huerkamp, Miller, Houle, and O’Jile (2007) found little 
association between phonemic fluency and anxiety in a mixed psychiatric 
sample of adults. 
Airaksinen, Larsson, & Forsell, (2005) further differentiated the impact 
of psychological distress by hypothesising that differences would be found in 
the effects of anxiety on executive functioning between different anxiety 
related conditions. They studied patients with a range of different anxiety 
disorders (panic disorder, social phobia, generalised anxiety disorder (GAD), 
obsessive-compulsive disorder (OCD), and specific phobia) on a range of 
executive functioning tests including phonemic fluency (FAS). Interestingly, 
they did find differences among the different anxiety conditions, some of 
which contrasted the results found by Talacchi et al., (2011). More 
specifically, Airaksinen et al., (2005) concluded that executive functioning 
(as measured by components of the Trail making test from the DKEFS) was 
impaired in patients who experience panic disorder and OCD, but not in 
patients who suffered from specific phobias or GAD. However, similar to the 
above studies they also found that phonemic fluency was not affected by 
anxiety in any of the groups (Airaksinen et al., 2005). These results support 
the idea that there are different mechanisms at play between different types 
of anxiety, and different types of executive functioning. It’s important to note 
however, that while the participants were selected based on their diagnostic 
category, their levels of anxiety at the time of testing were not measured 
(Airaksinen et al., 2005). As clinical diagnostic categories acknowledge 
fluctuations in presenting symptoms across time (American Psychiatric 
Association, 2013), this makes it significantly harder to imply any causal 
relationship between levels of anxiety and performance by using this 
approach. 
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Yochim et al. (2013) sought to uncover this more specific relationship 
between levels of anxiety and performance in executive functioning skills. 
They assessed older adult patients on a wider range of executive functioning 
assessments, looking at levels of anxiety at the time of testing (using the 
geriatric anxiety scale). Similarly to Airaksinen et al., (2005), they did find 
that higher levels of anxiety were associated with poorer performance on 
some executive functioning tests (the Trail making test and the 20 questions 
test from the DKEFS), but that anxiety did not predict performance in 
phonemic fluency (Yochim et al., 2013). They also investigated semantic 
fluency which, similar to phonemic fluency, was found to have no 
associations with anxiety (Yochim et al., 2013).  
O’Shea et al. (2016) conducted one of the only studies which has 
investigated both semantic and phonemic fluency in adults with varying 
levels of anxiety, looking more specifically at the interactions between 
fluency, anxiety and fatigue. They found that high anxiety increases 
performance in adults who were also fatigued (O’Shea et al., 2016). 
However, they were unable to rule out any underlying effects of depression, 
which is often present in people who are anxious, meaning these results 
could have been confounded by the effects of depression. Additionally, the 
same relationships with anxiety and verbal fluency performance were not 
apparent in individuals without high levels of fatigue, meaning that the 
relationships found were contextually contingent on the presence of fatigue 
and could not be extrapolated more generally to the adult population. 
It is very difficult to draw conclusions about how levels of anxiety may 
affect verbal fluency in adult patients with brain tumour, as these studies are 
not representative of this population. The above results provide some 
support for the idea that anxiety is likely to have a negative effect on a small 
range of executive functioning skills (Airaksinen et al., 2005; Yochim et al., 
2013) but that phonemic fluency (Airaksinen et al., 2005; Talacchi et al., 
2011; Yochim et al., 2013), and possibly semantic fluency (Yochim et al., 
2013) appear to be unaffected by anxiety in the same way. However, due to 
such a sparsity of results, particularly in the area of adult verbal fluency 
performance considered alongside anxiety during neurocognitive testing, this 
conclusion is weak and requires further exploratory investigation.  
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Summary of factors influencing verbal fluency 
Few studies have investigated the relationships between verbal 
fluency skills and the demographic, cognitive, tumour and mood factors 
discussed above. Those that have investigated these factors more 
consistently show significant relationships between phonemic fluency and 
age (Delis et al., 2001a; Tombaugh et al., 1999), gender (Loonstra et al., 
2001), education (Delis et al., 2001a; Gladsjo et al., 1999; Loonstra et al., 
2001), premorbid functioning (Bird et al., 2004; Crawford et al., 1992; Davis 
et al., 2017; Ross, 2003), semantic memory (Bird et al., 2004; Henry et al., 
2004; Riva et al., 2000) and depression (Brown et al., 1994; Henry & 
Crawford, 2005; Talacchi et al., 2011; Trichard et al., 1995). Age (Delis et 
al., 2001a; Tombaugh et al., 1999), education (Delis et al., 2001a; Gladsjo et 
al., 1999; Loonstra et al., 2001),  depression (Henry & Crawford, 2005) and 
semantic memory (Henry, Crawford, & Phillips, 2004; Riva et al., 2000) 
appear to be related to semantic fluency. However, the relationships 
between both types of fluency, anxiety and tumour grading are not clearly 
evidenced and therefore would benefit from further exploratory investigation.  
Localisation of verbal fluency 
Historically executive functions have been correlated with processes 
that involve the frontal cortex (Alvarez & Emory, 2006; Roca et al., 2010). 
Verbal fluency tasks are often considered to involve executive functioning 
skills, with research in this area often focused on the localisation of verbal 
fluency within different areas of the frontal lobes (see Henry & Crawford, 
2004 for a review). However, there is a significant lack of consistency 
between findings in studies looking into the localisation (or ‘localisations’) of 
verbal fluency, with a number of studies finding no correlation between 
certain outcomes of either semantic or phonemic fluency and lesion location 
or laterality (Babulal, 2016; Davidson et al., 2008; Vilkki & Holst, 1994). As 
discussed above, there are clear distinction between the cognitive processes 
of different types of verbal fluency, and so the research into the 
corresponding neural correlates should be reviewed separately 
(Szatkowska, Grabowska, & Szymańska, 2000). 
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Localisation of semantic fluency 
Broader lateralisation studies (as opposed to more specific 
localisation studies narrowing their focus down to more precise brain 
regions) appear to be quite contradictory when looking at semantic fluency 
deficits, with patients with right hemisphere lesions being more likely to show 
deficits over patients with left hemisphere lesions (Schweizer, Alexander, 
Susan Gillingham, Cusimano, & Stuss, 2010); other studies highlighted that 
semantic fluency deficits are more likely to be correlated with patients who 
have lesions in the left hemisphere (Goldstein et al., 2004; Vilkki & Holst, 
1994) while other studies have found no lateralisation effects at all (Klein et 
al., 2001; Robinson, Shallice, Bozzali, & Cipolotti, 2012).  
When looking at more specific localisation effects, semantic fluency 
has been correlated with a variety of areas within the cortex, including both 
the left and the right dorsolateral frontal lobes, both the superior and inferior 
medial frontal lobes, and the left temporal lobe (Troyer, Moscovitch, 
Winocur, Alexander, & Stuss, 1998). A different study has correlated 
semantic fluency performance with a similarly broad range of areas including 
the prefrontal cortex more generally, the right ventromedial areas and, 
similarly to the findings above, both the left and right dorsolateral frontal 
lobes (Szatkowska et al., 2000). One study focusing solely on the frontal and 
temporal lobes found similar deficits in semantic fluency outcomes between 
patients with lesions in these areas, implying that both areas are equally 
involved in the task, however, as they did not investigate any other cortical 
areas they were unable to justify the specificity of these results (Metternich, 
Buschmann, Wagner, Schulze-Bonhage, & Kriston, 2014). A similarly 
focused study using fMRI scanners has also highlighted specific correlations 
between semantic fluency performance and the left inferior frontal gyrus, the 
anterior cingulate, and the bilateral superior parietal gyri (Hirshorn & 
Thompson-Schill, 2006).  
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Localisation of phonemic fluency 
Outcomes of phonemic fluency have been slightly more refined in 
terms of the range of areas implicated as important, with a number of studies 
associating phonemic fluency performance with left frontal functioning 
(Metternich et al., 2014; Robinson et al., 2012; Szatkowska et al., 2000; 
Troyer, Moscovitch, & Winocur, 1997), in particular the left dorsolateral 
prefrontal cortex (Szatkowska et al., 2000; Troyer et al., 1997). Additionally 
the medial frontal lobe has been shown to play a role in phonemic 
performance (Crowe, 1992), more specifically the superior medial frontal 
lobe (Troyer et al., 1997). Again, there are a number of studies that 
contradict these outcomes, having found little or no correlational effects 
between localisation, or lateralisation and phonemic fluency performance 
(Babulal, 2016; Goldstein et al., 2004; Hoffermann et al., 2017; Vilkki & 
Holst, 1994). 
Summary of localisation effects of verbal fluency 
Outcomes of phonemic fluency studies more commonly associate 
phonemic fluency with left dorsolateral prefrontal cortex (Metternich et al., 
2014; Robinson et al., 2012; Szatkowska et al., 2000; Troyer et al., 1997). 
Other studies show that the superior medial frontal lobe also plays a role in 
phonemic fluency performance (Crowe, 1992; Troyer et al., 1997). A 
considerably broader array of cortical areas have been associated with 
semantic fluency performance, including the prefrontal cortex more 
generally, both the left and the right dorsolateral frontal lobes, both the 
superior and inferior medial frontal lobes, the right venture medial areas and 
the left temporal lobe (Szatkowska et al., 2000; Troyer et al., 1998). Other 
studies support the idea that even for patients who have cognitive deficits 
related to tumour localisation, they will still exhibit more global difficulties due 
to the requirement of cooperation of the brain as a whole neural network, as 
opposed to distinct areas of functioning (Hoffermann et al., 2017; Klein, 
2012). 
Despite this succinct summary, research in this area is often quite 
restricted, due to the difficulty of recruiting the high number of patients 
required to create an adequately powerful analysis because of the rarity of 
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the neurological conditions of interest. This has resulted in studies in this 
area being unable to statistically and reliably compare each of the cortical 
areas of interest once the sample has been collected and filtered 
appropriately (Goldstein et al., 2004). This is a common outcome in 
quantitative research attempting to focus on a number of variables whilst 
specialising in studying patients with relatively rare conditions, such as brain 
tumours or stroke (Baldo, Schwartz, Wilkins, & Dronkers, 2006; Crawford, 
2003; Crowe, 1992; Maxwell, 2004; Schweizer et al., 2010). This presents a 
problem, because there are such a wide range of factors that can influence 
the patient’s performance in any area of cognitive functioning.  
More specifically in relation to verbal fluency, as discussed above, 
depression (Henry & Crawford, 2005), age (Delis et al., 2001a; Tombaugh et 
al., 1999), gender (Loonstra et al., 2001), education (Delis et al., 2001a; 
Gladsjo et al., 1999; Loonstra et al., 2001), premorbid functioning (Bird et al., 
2004; Crawford et al., 1992; Davis et al., 2017; Ross, 2003) and semantic 
memory (Bird et al., 2004; Henry et al., 2004; Riva et al., 2000) have been 
shown to influence phonemic fluency outcomes. Similarly, depression, age 
and education appear to be related to semantic fluency (Delis et al., 2001a; 
Gladsjo et al., 1999; Henry & Crawford, 2005; Loonstra et al., 2001; 
Tombaugh et al., 1999). Depression in particular is a significant factor to 
consider given the strong evidence behind its influence (Henry & Crawford, 
2005) and potentially high levels of psychological distress in this population 
of individuals (Pringle et al., 1999; Zabora et al., 2001). Yet none of the 
localisation studies discussed above have considered the influence of this, 
or a number of the variables listed, let alone measured their interactions 
(Babulal, 2016; Goldstein et al., 2004; Hoffermann et al., 2017; Klein et al., 
2001; Metternich et al., 2014; Robinson et al., 2012; Schweizer et al., 2010; 
Szatkowska et al., 2000; Troyer et al., 1997, 1998; Vilkki & Holst, 1994). It is 
therefore possible that the contradictory/weak effects found within these 
localisation studies are present due to their lack of consideration for a 
comprehensive range of influential factors within their patient samples.  
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Research aims 
Verbal fluency tests are one of the most commonly used measures of 
executive functioning in neuropsychological testing and play an important 
role in the diagnosis of a number of conditions within the clinical population 
(Andreou & Trott, 2013; Pettit et al., 2013; Zhao et al., 2013). There is a 
notable lack of research in performance of patients with brain tumour pre-
surgery in measures of semantic and phonemic fluency, with the few that are 
in this area focusing on a wider range of neurocognitive impairments, as 
opposed to focusing more specifically on verbal fluency outcomes 
(Hoffermann et al., 2017; Klein et al., 2001; Miotto et al., 2011; Påhlson, Ek, 
Ahlström, & Smits, 2003; Talacchi et al., 2011; Tucha, Smely, & Lange, 
2001; Tucha et al., 2003). As a result there is little conclusive evidence 
about which factors may influence verbal fluency outcomes, more 
specifically in relation to semantic fluency (Bird et al., 2004; Davis et al., 
2017; Noll et al., 2014). There are no studies to date which have 
investigated the interactions between a comprehensive range of 
demographic variables, mood scores, and verbal fluency outcomes in 
patients with brain tumour. By facilitating a greater insight into these 
associations clinicians will have more evidence behind clinical decision 
making when considering the outcomes of this tool in patients with comorbid 
mood difficulties and other mitigating factors (in line with the variables this 
research considers). In addition, the ability to use lesion-behaviour mapping 
across two subcomponents of verbal fluency could allow for the application 
of a double dissociation model to increase the ability to draw inferences 
about the localisation of the different subcomponents of verbal fluency 
(Teuber, 1955). It is our belief that having a greater understanding of these 
relationships could enhance the clinical utility of this widely used cognitive 
assessment tool more generally, and within the brain tumour population 
specifically.  
This gap in the research base alone is noteworthy, however, 
answering the above questions would also be of great value to adding to and 
strengthening the evidence base surrounding the localisation effects of 
verbal fluency skills (Babulal, 2016; Goldstein et al., 2004; Hoffermann et al., 
2017; Klein et al., 2001; Metternich et al., 2014; Robinson et al., 2012; 
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Schweizer et al., 2010; Szatkowska et al., 2000; Troyer et al., 1997, 1998; 
Vilkki & Holst, 1994). By applying appropriate statistics to a large database, 
with a comprehensive range of variables that have been acquired by 
experienced clinicians, I aim to provide clinically meaningful results which 
clarify some of the contradictions in the research base to date. It is also 
hoped that the results will broaden clinicians’ understanding of the impact of 
these factors on verbal fluency, which will support them in making 
predictions about expected performance and tailor interventions accordingly.  
Study aims 
The aim of this study was to better understand the relationships 
between phonemic and semantic verbal fluency performance, tumour 
localisation, tumour type, tumour size, depression, anxiety, semantic 
memory, premorbid functioning, education and gender. More specifically the 
research questions were as follows:- 
Research questions 
1) Which tumour lesion localisations are most highly correlated 
with phonemic and semantic verbal fluency performance in patients with 
brain tumour? 
2) Which demographic, cognitive, mood, and tumour related 
factors best predict phonemic and semantic verbal fluency performance in 
patients with brain tumour?  
Hypotheses 
1) Scores on the FAS will be negatively associated with tumours 
located in the left dorsolateral prefrontal cortex and the medial frontal lobe, 
depressed mood (HADS-D), tumour size and patients with grade four tumour 
(in comparison to patients with lower grade tumours). 
2) Scores on the ANT will be negatively associated with tumours 
located in both the left and the right dorsolateral frontal lobe, the medial 
frontal lobes, the left temporal lobe, and depressed mood (HADS-D). 
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3) Scores on the FAS will be positively associated with the 
following: Semantic memory (GNT), premorbid functioning (TOPF), women 
(in comparison to men), and higher levels of education.  
4) Scores on the ANT will be positively associated with higher 
levels of education and semantic memory (GNT).  
5) Anxiety and tumour type will be investigated to explore any 
relationships with the FAS and the ANT. 
Method 
Study design 
This was a quantitative study with a retrospective cohort design of 
cross-sectional data routinely collected in the Neuropsychology Department 
at James Cook Hospital as part of their service into the neuro-oncology 
multi-disciplinary team (MDT). The analysis looked at the associations 
between verbal fluency performance, brain tumour location and the role of 
other potential mediator variables. More specifically the variables of interest 
were as follows:- 
Criterion/dependent variables of interest 
Phonemic fluency 
Semantic fluency 
Main predictor independent variable of interest 
Tumour Localisation  
Mediator predictor independent variables of interest 
Depression  
Anxiety 
Semantic memory 
Premorbid functioning 
Tumour Type  
Tumour Size 
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Gender 
Education  
Data collection 
Data was provided by the Neuropsychology department within the 
Medical Psychology Team at James Cook University Hospital (under South 
Tees Hospitals NHS Foundation Trust). The data came from a database 
they held consisting of information routinely collected as part of their service 
into the neuro-oncology multi-disciplinary team (MDT). Due to the data being 
provided by the service consisting of information routinely collected as part 
of their service evaluation data, patient consent specific to this study was not 
required. The research proposal was reviewed and approved by the 
Research and Development Service in South Tees Hospitals NHS 
Foundation Trust and The School of Medicine Ethics Committee who 
granted ethical approval for the study. This department received referrals 
from County Durham, Teesside, Darlington, and North Yorkshire for patients 
that were being considered for tumour resection and/or for assessment and 
support with managing cognitive/emotional difficulties. Participant data was 
selected to be included in the study if they met the following criteria at the 
time they attended for assessment:- 
• They had received a formal diagnosis of brain tumour. For 
patients proceeding to tumour resection this diagnosis will have been 
confirmed by a neuropathologist. For those who were not referred for 
surgery their diagnosis will have been made by a neuroradiologist 
• They were referred for neuropsychological assessment at the 
neuropsychology department, within the Medical Psychology Team at James 
Cook University Hospital (under South Tees Hospitals NHS Foundation 
Trust) following a diagnosis of brain tumour 
• They had attended for assessment between January 2011 and 
July 2017 prior to receiving surgery, chemotherapy or radiotherapy 
• They were aged 18 or over 
• Their first language was English 
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• They had completed the all the tests of interest to this study 
(listed below) as part of the service’s standard battery of assessments. 
A staff member affiliated with both the neuropsychology service and 
the research team extracted the data from the database based on the 
eligibility criteria (above). This staff member anonymised all of the data 
before it was securely transferred to the researcher. This data include some 
patient demographics (education and gender) as well as scores for each of 
the relevant assessment tools and information about the tumour type, size 
and localisation. Localisation was initially coded prior to the dataset being 
obtained by the researcher by the neurosurgery team using CT head scans. 
Operationalisation and coding of variables 
Criterion/dependent variables  
FAS Test (Phonemic fluency) 
One of the first verbal fluency tests was developed by Thurstone in 
1938 as a means for assessing letter fluency in a written format (Thurstone, 
1938, as cited in Delis, Kaplan, & Kramer, 2001). This test has since been 
developed into a test of phonemic fluency made readily accessible for 
clinician with normative data published in a range of papers (Gladsjo et al., 
1999; Loonstra et al., 2001; Rodriguez-Aranda & Martinussen, 2006; Strauss 
et al., 2006; Tombaugh et al., 1999). The FAS test requires participants to 
produce words starting with the letters F, A or S (within the set time period of 
60 seconds). The participant is restricted from providing words that were 
names (e.g. Andy), places (e.g. Antarctica), or the same words with different 
endings (e.g. aim, aims, and aiming). The participant is also restricted from 
repeating the same words or producing words that do not start with the 
allocated letter. Any violations of these restrictions result in an error score 
and the word not being counted as part of the outcome score. The number 
of correct words produced for each category were tallied, and an average 
score is produced from the three categories as the overall outcome. This 
was then converted to a scaled score using information summarised in 
Strauss et al., (2006). The use of scaled scores provide a robust method to 
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attenuate the effects of outliers and normalise distributions of multiple 
neuropsychological tests using a common metric (Tabachnick & Fidell, 
2013). The data for this test was included as a single continuous variable 
using the scaled scores. 
Animal Naming Test (Semantic fluency) 
One of the first researchers to introduce category fluency procedures 
in experimental studies of patients with brain damage was Rosen (Rosen, 
1980). The most commonly used category to measure category fluency is 
under the subject “animal” (often referred to as the ANT). This has been 
made readily accessible for clinician use as a standalone assessment using 
normative data stratified by age and education published by Tombaugh et 
al., (1999). The total score is calculated based on the number of animals that 
have been listed within the set time period (60 seconds). The participant is 
also restricted from repeating the same words or producing words that do 
not start with the allocated category. Any violations of these restrictions 
result in an error score and the word not being counted as part of the 
outcome score. This was then converted to a scaled score using information 
summarised in Strauss et al., (2006). The use of scaled scores provide a 
robust method to attenuate the effects of outliers and normalise distributions 
of multiple neuropsychological tests using a common metric (Tabachnick & 
Fidell, 2013). The data for this test was included as a single continuous 
variable using the scaled scores. 
Predictor/independent variables 
Tumour Localisation 
Due to the database involving input from a variety of clinicians over a 
long period of time, and the vast nomenclature used among tumour 
localisations, the initial dataset included a wide range of different tumour 
localisations. To prepare this data for analysis the researcher created a 
number of higher-order codes which were then verified independently by two 
clinicians from the neuropsychology department, with the aim of increasing 
interrater reliability of the codes created (see Appendix A).  
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Further revisions of the statistical model were required when it 
became apparent that fewer variables were needed to increase the power of 
the analysis (see Appendix B). Due to this category 2 was condensed down 
into two new data coding sets to consider. Initially category 4 was created 
which included seven main localisation areas including the localisation 
category of ‘other’ which included an amalgamation of the data points which 
did not fit the main six selected localisations. These main six locations were 
selected based on the lobes of the brain most likely to be involved in 
cognitive tasks (frontal, parietal and temporal). This was with the aim of 
retaining as many data points as possible. However, as the data points that 
did not meet the main six localisations came from dispersed locations 
throughout the brain, coding them as ‘other’ and including them in the 
analysis would not be meaningful to the hypothesis. Category 5 was then 
created with the ‘other’ group data points coded as ‘missing data’. It was 
considered that the increase in power gained by the reduction of four 
variables was likely to outweigh the power lost in the reduction of data points 
included, based on the rough principles of needing 10 participants per 
variable. Coding reliability for localisation was assessed using the Kappa 
statistic. The outcome for each of the five categories described above was a 
score of 1. As this demonstrated perfect agreement no further analyses were 
required. The analyses were completed using the coding for category 5. This 
variable is categorical and was therefore transformed into a range of ‘dummy 
variables’, in line with the chosen higher order groupings, in preparation for 
use in the analysis. 
Tumour Type 
Data for tumour type was also provided in a range of specialised 
classifications. These classifications were similarly grouped into higher order 
codes, as described in more detail below (see Appendix C).  
In reviewing the tumour types across the database it became 
apparent that patients with ‘cysts’ had been included in the data. While a 
cyst is still likely to create cognitive difficulties through increase in 
oedema/pressure, the nature of a cyst differs from tumours in terms of not 
being likely to infiltrate tissue, meaning the effects are likely to be more 
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variable in nature. Due to this the impact is slightly different and it was felt 
that this data should be excluded from the study to maintain the 
homogeneity of the population group being studied. The remaining tumour 
types were initially grouped into four categories with a focus on specificity. 
However, further revisions of the statistical model highlighted that fewer 
variables were required to increase the power of the analysis. Due to this 
category 1 was condensed down into a dichotomous variable consisting of 
the main two tumour types, glioma and meningioma. The other data points 
were coded as ‘missing data’ using the same process as for localisation. It 
was considered that the increase in power gained by the reduction of three 
variables was likely to outweigh the power lost in the reduction of data points 
included, based on the rough principles of needing 10 participants per 
variable. Coding reliability for tumour type was assessed using the Kappa 
statistic. The outcome for both category one and the dichotomous variable 
coding described above were scores of 1. As this demonstrated perfect 
agreement no further analyses were required. The analyses were completed 
using the dichotomous variable for glioma and meningioma. 
Tumour Size 
Data for tumour size was provided in two dimensions (two separate 
width values). These values were combined to create a single variable 
providing a surface area estimate by multiplying the two width scores 
together. This surface area value was recorded for each data point and used 
in the analysis as a single continuous variable. 
Hospital Anxiety and Depression Scale (Anxiety and Depression) 
The Hospital Anxiety and Depression Scale (HADS) is a self-report, 
14 item screening tool, with two subscales (seven items each) which assess 
for levels of anxiety and depression. The scores can be separated for 
anxiety (HADS-A) and depression (HADS-D). It was developed by Zigmond 
& Snaith, (1983) specifically to avoid reliance on common somatic symptoms 
of illness, for example insomnia and fatigue, with the aim of being a more 
valid and reliable measure to use to assess anxiety and depression in 
people with physical health problems. The internal consistency of this scale 
has been demonstrated to be high, with Cronbach’s α ranging between 0.67 
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and 0.90 for the HADS-D, and 0.68 and 0.93 for the HADS-A (Bjelland, Dahl, 
Haug, & Neckelmann, 2002; Smarr & Keefer, 2011). The HADS has been 
correlated against the Beck Depression Inventory and the General Health 
Questionnaire to show adequate levels of validity, with coefficients ranging 
between 0.60 and 0.80 (Bjelland et al., 2002; Julian, 2011; Smarr & Keefer, 
2011). 
The HADS is quick to administer (about five minutes) and the 
responses are focused on the relative frequency of symptoms experienced 
by the participant over the last week. Items are scored on a Likert scale 
ranging from 0 to 3 (0 = not at all; 3 = very often). Therefore the scores 
derived for each subscale (anxiety or depression) can range between 0 – 21, 
with higher scores indicating greater likelihood of depression or anxiety. The 
test authors suggest that raw scores of between 8 and 10 identify mild 
cases, 11 – 15 identify moderate cases and 16 or above indicate serve 
levels of anxiety or depression (Zigmond & Snaith, 1983). The cut-off point 
of 8/21 for caseness in both anxiety and depression has been suggested, 
which gives a specificity of 0.78 and 0.79 and a sensitivity of 0.9 and 0.83 for 
anxiety and depression respectively (Bjelland et al., 2002). This cut off point 
was used to create dichotomous categorical variables for anxiety and 
depression separately, where scores of 0-7 were coded as ‘not 
depressed’/‘not anxious’ and scores of 8-21 were coded as 
‘depressed’/‘anxious’ for HADS-D and HADS-A respectively. 
Graded Naming Test (Semantic memory) 
Deficits in a person’s ability to retrieve the name of an object is often 
the first indication of impaired language functioning. The Graded Naming 
Test (GNT) is a commonly used language assessment more specifically 
focused on semantic memory, which was developed by McKenna and 
Warrington (1980). They demonstrated good validity for this test by 
correlating it (.69 and .73) with two separate tests of reading (Mckenna & 
Warrington, 1980). Bird et al., (2004) tested reliability in the normal 
population using a one month follow up period, showing a reliability 
coefficient of .92 (p < .001). Within clinical populations (patients with 
neurodegenerative disorders) high test-retest reliability was also found at .93 
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(Bird & Cipolotti, 2007), however, low intra-subject variability was also 
apparent in this study, resulting in the authors suggesting new reliable 
change indices for neurological patients (+/-4.6). Its approach of grading the 
levels of difficulty throughout the test helps to avoid the problem of ceiling 
effects, meaning that the GNT is often chosen above other types of naming 
test. Participants are shown 30 black and white line drawings/pictures 
(graded and ordered by difficulty) and asked to say what the picture is. The 
total score is calculated via the total correct answers given. This score was 
recorded for each data point and used in the analysis as a single continuous 
variable. 
Test of Premorbid Functioning (Premorbid functioning) 
Reading tests have historically been used to predict premorbid IQ 
based on the concept that reading skills have been shown to be less 
susceptible to brain injury or decline than other cognitive skills (Crawford, 
2003; Johnstone, Hogg, Schopp, Kapila, & Edwards, 2002). The Test of 
Premorbid Functioning (TOPF) is a reading test which can be used to enable 
clinicians to estimate an individual’s level of intellectual functioning before 
the onset of injury or illness (D Wechsler, 2011b). It requires the participant 
to read aloud words with irregular spellings that have an atypical grapheme 
to phoneme translation. As these words cannot be decoded phonologically 
the correct pronunciation is thought to come from the participant’s 
knowledge of the word acquired prior to their cognitive deterioration. The 
outcome can provide estimates, based on population norms, of a range of 
areas of premorbid intellectual functioning, as well as a general premorbid 
intelligence score. This type of test score can be calculated in conjunction 
with demographic variables to provide a more powerful prediction of 
premorbid functioning than other methods/tests available (Crawford, 
Stewart, Parker, Besson, & Cochrane, 1989; Reynolds, 1997). Test-retest 
reliability was calculated from a sample of 293 examinees from the US who 
completed the test twice, with about a 3 week interval (Wechsler, 2008). This 
was then analysed by age group with the correlation scores ranging between 
.89 and .95 (Wechsler, 2011). The internal consistency of the test was 
calculated on a standardisation sample from the UK, using total scores of 
the two half-tests, corrected for length of the test using the Spearman-Brown 
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formula. The outcomes indicated a high level of internal consistency, with a 
Chronbach’s α of 0.95 (95% CI = 0.94 to 0.96) and a split-half reliability 
coefficient of 0.95 (Wechsler, 2011).  
The participant is asked to read aloud from a list of 70 words (graded 
and ordered by difficulty). The test is terminated at the point where the 
individual scores 0 for five answers in a row and the score is calculated by 
the number of correct responses prior to this point. This total score was 
recorded for each data point and used in the analysis as a single continuous 
variable. 
Gender 
Data for gender was provided as either ‘male’ or ‘female’ and 
therefore coded as a dichotomous categorical variable with these same 
codes.  
Education 
Data for education was provided as either ‘no exams’ or as a range of 
qualifications beginning with CSE and ending with degree. This range was 
initially coded as a categorical variable with a separate level for each type of 
qualification. However, due to further revisions of the statistical model due to 
the decision to increase the power of the analysis through decreasing the 
number of variables, it was decided to code this variable as a dichotomous 
categorical variable with two levels, ‘no exams’ and ‘exams’.  
Power analyses and sample size estimation 
In this study there were two criterion/dependent variables for the 
verbal fluency outcome (FAS Score and ANT Score), each of which were 
analysed against the main predictor variable (tumour localisation) and seven 
mediator predictor variables (HADS Depression, GNT score, TOPF score, 
tumour type, tumour size, education and gender).  
The initial statistical model was based on the localisation category 
having 18 levels, therefore counting as 17 predictor ‘dummy’ variables (see 
table X, Category 1), tumour type having five levels, therefore counting as 4 
predictor ‘dummy’ variables (see table X, Category 1) and education having 
six levels, therefore counting as 5 predictor ‘dummy’ variables. Combined 
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with the above listed variables of interest that totalled the number of 
predictor variables to consider in the power analysis to 31. 
In planning the study two power analyses were considered:- 
1) It is recommended that the data set should contain at least 10 
times the number of participants as you have predictor variables to ensure 
stability and reliability when completing multiple regression (Harrell, 2001). If 
this analysis were to retain the 31 variables, an expected sample size of 123 
would not be considered adequate. 
2) To take a more specific approach we considered effect sizes. 
Cohen (1988, 1992) advises an order of magnitude for the effect size with 
0.02 being appropriate for a small effect, 0.15 for a moderate effect and 0.35 
for a strong effect. This has been defined using the following equation for 
multiple regression calculations:- 
 
It is expected that the larger the effect size, the smaller the sample 
size required. In line with this G*Power (Faul, Erdfelder, Buchner, & Lang, 
2009) was used to calculate a priori power analysis for a multiple regression 
with 31 predictors, an alpha value of .05 and an aim to achieve a power of .8 
(80%). This calculation indicated that a sample size of 96-190 would be 
required to detect a medium to large effect size as outlined by Cohen above. 
Therefore, the expected number of participant data sets were unlikely to be 
sufficient to meet the aims of the project. 
As described above the model was revisited and refined resulting in a 
number of the categorical variables being reduced. Some were reduced to 
dichotomous variables, e.g. tumour type, education and gender) and 
localisation was reduced to six levels. As tumour localisation has six levels it 
requires five ‘dummy variables’ for the analysis, meaning that localisation will 
count as five variables. This means that each analysis had twelve predictor 
variables to account for. When G*Power (Faul et al., 2009) was used to 
calculate a priori power analysis for a multiple regression with twelve 
predictors, an alpha value of .05 and an aim to achieve a power of .8 (80%). 
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This calculation indicated that a sample size of 61-127 would be required to 
detect a medium to large effect size as outlined by Cohen above. Therefore, 
the expected number of participant data sets were sufficient to meet the 
aims of the project. 
Data analysis 
Demographic characteristics of the data set were evaluated and 
reported. The criterion/dependent variable was the verbal fluency outcomes 
as measured by the scaled scores corresponding to the average of the three 
phonemic fluency trials (F, A, S) and the total number of responses obtained 
from the ANT. The main predictor variable was tumour localisation (as coded 
by the neurosurgery team, using CT head scans). The control/predictor 
variables were mood (as measured by the anxiety and depression scores 
from the HADS), semantic memory (as measured by the GNT), premorbid 
functioning (as measured by the TOPF), tumour histology (size of tumour 
and tumour type), education and gender. All analyses were conducted using 
IBM SPSS Statistics software version 24. An alpha level of .05 was used to 
define statistical significance. 
Data inclusion 
Data was available for 123 participants who were included in this 
study. Six cases were removed following the discovery that these cases 
were cysts instead of tumours during the coding of tumour type, leaving a 
data set of 117 participants. Within this data 117 participant cases included 
data on gender, TOPF score, FAS score, ANT score, GNT score, and both 
versions of the HADS. Some data was missing for the other categories of 
interest, either due to the data being missing on acquisition from the service, 
or due to the points being excluded through the coding process (explained 
above). Therefore, despite 117 cases being used in the analysis, there was 
a reduction in the total available to analyse for education (110), tumour type 
(113), tumour localisation (91) and tumour size (41). This is explained in 
more detail in the flow chart below:- 
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Figure 1. Flow chart of data retention 
 
  
123 participant 
data sets 
provided
•6 data sets removed following refinement of inclusion 
criteria for tumour type
117 participant 
data sets 
retained 
•Data assessed for missing data in line with new 
coding categories for tumour type, leading to 5 
participant data sets being removed
104 participant 
data sets 
retained for 
tumour type
•7 data points classified as 'missing data' in the 
education category110 participant 
data sets 
retained for 
education
•13 data points classified as 'missing data' in the 
tumour type category
91 participant 
data sets 
retained for 
localisation
•26 data points classified as 'missing data' in the 
tumour localisation category
80 participant 
data sets 
retained with 
data in all 
categories
•When the data is cross-analysed for missing data 
points 37 data sets were missing data in one or more 
categories. This means that any 'listwise' analyses 
would use the remaining 80 participants who have full 
data sets 
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Results 
Demographics 
As described in the method, the inclusion criteria for participant data 
selection were:- 
• They had received a formal diagnosis of brain tumour. For 
patients proceeding to tumour resection this diagnosis will have been 
confirmed by a neuropathologist. For those who were not referred for 
surgery their diagnosis will have been made by a neuroradiologist 
• They were referred for neuropsychological assessment at the 
neuropsychology department, within the Medical Psychology Team at James 
Cook University Hospital (under South Tees Hospitals NHS Foundation 
Trust) following a diagnosis of brain tumour 
• They had attended for assessment between January 2011 and 
July 2017 prior to receiving surgery, chemotherapy or radiotherapy 
• They were aged 18 or over 
• Their first language was English 
• They had completed the all the tests of interest to this study 
(listed below) as part of the services standard battery of assessments. 
Data for 123 participants met this criteria and so were initially included 
in the study. The age range was 22 to 90 years old, with a mean age of 
54.56 and a standard deviation of 15.5. The categorical demographic 
variables are displayed in table 1. There were 52 males (42.3%) and 71 
females (57.7%) in the sample. The majority identified themselves as 
predominantly right-handed (109, 88.6%) with 14 left-handed (11.4%) and 
no one identifying themselves as ambidextrous. In terms of education, 10 
participants had been educated to degree level (8.1%), 16 had completed 
further education (13%), three had achieved A levels (2.4%), 27 had CSE 
level qualifications (22%), 28 had GCSEs (22.8%), which when 
amalgamated into the category ‘educated’ meant that 64 (74%) of 
participants were educated and 32 (26%) had no academic qualifications. 
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Table 1. Frequency data for demographic categorical variables 
 Category Frequency 
(n, %) 
Valid Missing  
(n, %) 
Handedness Left Handed 14, 11.4 123 0, 0 
Right Handed 109, 88.6   
Gender Male 52, 42.3 123 0, 0 
Female 71, 57.7   
Education No exams 32, 27.6 116 7, 5.7 
 
GCSE 28, 24.1   
CSE 27, 23.3   
A level 3, 2.6   
Further 
education 
16, 13.8   
Degree 10, 8.6   
 
Tumour characteristics 
Tumour size was the only continuous tumour data variable and data 
was available for 41 participants. The mean size was 966.63, range 256 - 
3888mm2, with a standard deviation of 744.28.  
Data from six participants were removed due to the tumour type being 
a cyst as opposed to a tumour, five were other types of tumour, and two 
participant’s tumour types had not been recorded. The remaining data on 
tumour type included 21 (17.9%) gliomas, 83 (70.9%) meningiomas and 13 
(9.1%) classified as ‘other’ and then ‘missing’ in the higher order 
categorisation process.  
Coding for localisation as described in the method section resulted in 
six categories, with the smallest frequency being for tumours situated in the 
left parietal lobe (4, 4.4%) and the largest in the left frontal lobe (44, 37.6%). 
There was missing localisation data for 26 participants (22.2%). Table 2 
illustrates this data. 
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Table 2. Frequency data for categorical variables related to tumour 
factors 
 Category Frequency 
(n, %) 
Valid Missing 
(n, %) 
Tumour type Glioma 21, 18.3 115 2, 1.7 
Meningioma 83, 72.2 
Missing/Other 11, 9.6 
Tumour 
localisation 
Frontal 6, 5.1 117 26, 22.2 
Left Frontal 44, 37.6 
Left Parietal 4, 4.4 
Left Temporal 7, 7.7 
Right Frontal 24, 26.4 
Right Parietal 6, 6.6 
 
Neurocognitive and mood assessment 
In terms of the neuropsychological assessments included in the data 
set, each assessment had a valid data point for each participant case, 
meaning there was no missing data among these variables. The FAS scores 
ranged between 2 and 17 with a mean of 8.28. The ANT had a very similar 
range to the FAS (1 – 18) with a mean of 8.52 and the GNT scores ranged 
between 2 and 28, with a mean of 19.47. The scores for the TOPF ranged 
from 13 to 67, with a mean of 39.98. The mood measures both had the 
same range (0-20), with HADS-A having a mean of 8.68 (with 56.9% of 
participants meeting the criteria for caseness/anxiety) and HADS-D being 
6.12 (with 35% of participants meeting the criteria for caseness/depression). 
This data is illustrated in table 3 and a more detailed breakdown of the 
frequency distribution of the scores for depression can be viewed in 
Appendix D, and for anxiety can be viewed in Appendix E. 
Table 3. Frequency data for neurocognitive and mood factors 
 Valid Missing  
(n, %) 
Frequency 
(n, %) 
Mean Min Max 
FAS 123 0, 0 123, 100 8.27 2.0 17.0 
ANT 123 0, 0 123, 100 8.52 1.0 18.0 
TOPF 123 0, 0 123, 100 39.98 13.0 67.0 
GNT 123 0, 0 123, 100 19.47 2.0 28.0 
HADS A 123 0, 0 123, 100 8.68 .0 20.0 
HADS D 123 0, 0 123, 100 6.12 .0 20.0 
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Data cleaning 
The dataset contained a number of variables with missing data. Of 
most significance, usable data for tumour size was found only to be present 
in 41 cases (66.7% missing) and each of these cases fell into the tumour 
type category of meningioma. Due to the limited data available for this 
variable and the fact that it is not randomly dispersed among the other 
variables, it was removed from further analysis.  
Each variable was analysed to assess the rates of missing data. 
There were no missing data for any of the continuous variables, but missing 
data was found among three of the categorical variables (tumour type at 
1.7%; education with 5.7%, and tumour localisation at 22.2%). Little’s 
‘Missing Completely at Random’ (MCAR) chi square statistic was calculated 
for all variables to test whether there was any systematic pattern to the 
missing data (Little 1988; Graham, 2009). The Little chi-square test shows 
little evidence that data is missing other than MCAR (Chi-Square = 13.183, 
DF = 7, Sig. = .068), and so MCAR is assumed. Consequently complete 
case analysis is assumed to be unbiased by missing data. 
Missing data can result in a reduction of statistical power. This is often 
accounted for by using imputation methods such as ’mean imputation’ which 
replaces the missing values with a mean score for that data set (van der 
Heijdena, Donders, Stijnene, & Moons, 2006; Little & Rubin, 2014). 
However, due to the missing data in this set being exclusively from dummy 
categorical variables relating specifically to clinically meaningful binary 
outcomes (e.g. tumour type), imputation methods would risk diluting the 
clinical meaning behind the results discovered. Therefore, the missing data 
were labelled to be recognised by the statistical analysis software and 
accounted for through listwise deletion within the relevant analyses.  
Assessing normality of the continuous variables 
The continuous variables were assessed for the normality 
assumptions of a regression analysis initially through exploration of the 
distribution of the data using histograms and Q-Q plots. It was felt that a 
relatively normal bell curve was visible in most of the variables histograms. 
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Two exceptions to this were the graphs for HADS-D and the GNT, which will 
be described in more detail below in figures 2-5. 
Figure 2. Histogram showing distribution of data for the HADS-D 
 
As might be expected the HADS Depression histogram (see figure 2) 
appears to be slightly positively skewed with two distribution peaks and it 
does look like a somewhat leptokurtic tail, particularly to the left of the 
distribution.   
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Figure 3. Normal and Detrended Q-Q Plots for the HADS-D data 
 
 
This normal Q-Q plot (see figure 3) has a slight positive skew (a slight 
shift in the data away from the bisection line, at the tail ends, with the tail 
ends below the bisection line and the middle data above the line). 
Additionally the tail ends are slightly heavy (more spaced out). The de-
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trended Q-Q plot also supports the view of a positive skew due to the ‘v’ 
shape scatter. 
Figure 4. Histogram showing distribution of data for the GNT 
 
The GNT histogram (see figure 4) appears to be somewhat negatively 
skewed with a leptokurtic tail, particularly to the right of the distribution where 
there is a relative lack of a graded ending.  
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Figure 5. Normal and Detrended Q-Q Plots for the GNT data 
 
This normal Q-Q plot (see figure 5) has a slight negative skew (a 
slight shift of the data away from the bisection line at the tail ends, with the 
tail ends above the bisection line and the middle data below the line). 
Additionally the tail ends are slightly heavy (more spaced out) than the data 
across the middle of the pattern. The de-trended Q-Q plot also supports the 
view of a negative skew. 
To more rigorously assess the continuous variables in this data set for 
normal distribution SPSS provides two statistical tests, the Kolmogorov-
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Smirnov and the Shapiro-Wilk. The results from the Kolmogorov-Smirnov 
test highlighted that age was the only variable that did not have a significant 
outcome (and hence did meet the assumptions of normality). However, the 
Kolmogorov-Smirnov test is commonly considered to be overly conservative, 
with a high sensitivity to extreme values and a low power. This means it is 
likely to lead to systematic errors and is now traditionally ignored by 
researchers (Ghasemi & Zahediasl, 2012; Steinskog, Tjøstheim, & Kvamstø, 
2007). The significant results from the Shapiro-Wilk outcomes for each 
variable indicate that none of the variables meet the assumptions of 
normality. However, these outcomes need to be interpreted with caution, as 
it is commonly accepted that due to the increase of power in large sample 
sizes, and the unrealistic likelihood that perfectly normally distributed data 
will exist in real population data, even very small deviations from normality 
will result in a significant outcome on the Shapiro-Wilk test (Öztuna, Elhan, & 
Tüccar, 2006). Due to this SPSS recommends that data sets containing 
more than 50 cases do not rely on this statistic to guide the treatment of their 
data, but instead act as an indicator to assess the variables in more depth 
via other means (Elliott & Woodward, 2007).  
Following this guidance the researcher calculated Z-scores for the 
skewness and kurtosis statistical outcomes for each variable (see table 4) 
using the following calculations: 
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Table 4. Skewness and Kurtosis Z value calculations for continuous 
variables 
 TOPF FAS ANT GNT 
HADS 
A 
HADS 
D 
N Valid 123 123 123 123 123 123 
Missing 0 0 0 0 0 0 
Mean 39.984 8.276 8.520 19.472 8.675 6.122 
Skewness .211 -.013 -.310 -.882 .374 .571 
Std. Error of 
Skewness 
.218 .218 .218 .218 .218 .218 
Skewness Z 
Score 
0.97 -0.06 -0.60 -4.05 1.72 2.62 
Kurtosis -.587 -.249 .052 1.030 -.438 .113 
Std. Error of 
Kurtosis 
.433 .433 .433 .433 .433 .433 
Kurtosis Z Score -1.36 -0.58 0.12 2.38 -1.01 0.26 
 
The Z-Score is considered significant at P < 0.05 if it is greater than 
1.96 or lesser than -1.96, however, it is advised that for larger samples the 
criterion should be changed to + or – 2.58, and very large samples should 
not be assessed for normality at all (Field, 2009; Ghasemi & Zahediasl, 
2012). So within these guidelines there are two variables that exhibit a level 
of skewness which are considered to violate the normality assumptions 
(HADS-D, which is only just past the significance cut-off, and GNT which is 
slightly more skewed at -4.05).   
The outliers for these two variables were viewed through boxplot 
graphs (HADS-D had one outlier at participant 2, GNT had three outliers at 
participants 1, 70 and 110). Removal of these outliers was considered, 
however it was felt that due to the naturally variable nature of clinical 
population data it would risk reducing the validity of the research outcomes 
by removing data in this way. Therefore, it was decided that the outliers 
would continue to be included in the analyses.  
Transformations of these two variables were attempted (using a 
LOG10 transformation), however, the transformations created greater 
deviations from normality than was originally present within those variables.  
When regression calculations are conducted with a large enough 
sample size (some have placed a numerical value on this of about 35+), 
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small violations in normality assumptions shouldn’t cause significant 
difficulties with the outcomes of the analysis (e.g. Pallant, 2007). 
Furthermore, it has been stated that if a sample consists of hundreds of 
observations, it is acceptable to ignore the distribution of the data entirely 
(Altman & Bland, 1995; Field, 2009; Ghasemi & Zahediasl, 2012). This 
database contains over 100 cases, the visual assessment of the histograms 
and Q-Q plots were relatively normal for all variables, and the two variables 
that demonstrated slight deviations from normality were independent 
variables (which are of less concern than the dependent variables). It would 
therefore be fair to assume that slight statistical deviations in normality 
distribution can be considered ignorable and the use of parametric 
procedures is acceptable with this dataset. 
Assessing for linearity, independent errors and 
homoscedasticity 
To test whether the outcome variable is related linearly to each of the 
predictor variables the standardised residuals were plotted against the 
standardised predicted values for each of the dependent variables. The 
points are relatively well scattered across negative and positive values 
(largely between the ideal range of -3 and +3) with no obvious pattern. This 
is more the case for the FAS (see figure 6), however, both variables produce 
an acceptable amount of scatter in the plotted residuals so there is no 
reason to doubt the linearity assumption. Similarly this pattern shows that 
the residuals don’t indicate autocorrelation and so the errors are normally 
distributed and the independent errors assumption is met. The scatter and 
the residual statistics also indicate that the variance of the residuals are 
constant and so the assumptions of homoscedasticity are also met (see 
figure 7 and table 5). 
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Figure 6. P-P Plot for FAS data 
 
Figure 7. Scatterplot for FAS data 
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Table 5. Residual statistics for FAS data 
 
 
Minimum Maximum Mean SD N 
Residual -6.9041 7.0687 .0314 2.5831 102 
Std. Residual -2.442 2.500 .011 .914 102 
Cook’s Distance .000 .160 .012 .024 101 
Centered Leverage .064 1.060 .231 .132 102 
 
Assessing for multicollinearity 
The correlation matrix was viewed (see appendix Fi and Fii) to assess 
the correlation coefficients for each pair of explanatory variables. The 
correlation coefficient is considered appropriate if it is less than -0.8 or 
greater than 0.8 (Petrie & Sabin, 2009). Each correlation coefficient in this 
data set met these requirements and so there were no concerns relating to 
multicollinearity. In line with this the tolerance collinearity statistic for each 
variable was relatively high (lowest value being 0.437 for age) and higher 
than the 0.2 error indicator. Similarly, the variance inflation factor collinearity 
statistics are all lower than the cut off of 10 (highest value 2.289, again for 
age). These outputs indicate that the multicollinearity assumptions have 
been met. 
Statistical analyses 
To test the study hypotheses analytic statistics were conducted using 
IBM SPSS Statistics 24, in the form of multiple linear regression. The 
assumptions for this model were met within the data set as described above. 
This particular statistical method was chosen because there were multiple 
predictor variables, and multiple linear regression allows for the 
determination of which predictors are significantly associated with the 
independent (criterion) variable, while taking into account that the predictors 
may be related to each other (Howitt & Cramer, 2005). Within this approach 
the method of hierarchical linear regression was employed due to there 
being specific hypotheses developed based on theories derived from 
previous research in relation to the role of tumour localisation in phonemic 
fluency performance (Field, 2009). In line with this the localisation variable 
was added to the model in the first stage of the regression, with the predictor 
variables whose assumed influence was more clearly supported by prior 
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research entered second (gender and education); additional predictor 
variables added in the second stage. Significance was assessed at an α 
level of 0.05.  
Due to the unexpected loss of usable data through the data cleaning 
and categorising process, particularly when considering the hierarchical 
multiple regression analyses (reducing from 123 to 80 cases) with a 
relatively high number of variables, a post hoc power analysis is 
recommended to determine the chance of the results being due to a type 2 
error. G*Power (Faul et al., 2009) was used to calculate a post hoc analysis 
for each of the regression analyses based on their number of predictors, 
their sample size, an alpha value of .05, and an f2 effect size calculated 
using the R2 value provided in the analysis results.  
To control for the false discovery rate associated with multiple 
comparisons the Benjamini-Hochberg procedure (Benjamini & Hochberg, 
1995) was used to adjust the P values, using a false discovery rate of .1. 
This rate was chosen to balance the high rate advised in the use of 
hypotheses that are quite explorative in development (due to a limited 
evidence base), whilst attempting to ensure potential false positive results 
are controlled for as stringently as possible. 
Associations between verbal fluency and demographic 
factors 
Single linear regressions were calculated to predict phonemic fluency 
(FAS scores) based on education and gender. Phonemic fluency and 
education were significantly correlated (F(1,115) 7.639 p=.007), with an R2 
of .066 for the effects of education, an f2 effect size of 0.071 and a power (1-
β) of 0.782. Participants’ predicted FAS score was equal to 6.906 + 1.966 
(education) where education is coded as 0 = no exams, 1 = educated. 
Participants’ mean FAS score increased by .091 for participants who were 
educated. Phonemic fluency and gender were not significantly correlated 
(F(1,115) 1.664 p=.200), with an R2 of .014 for the effects of gender, an f2 
effect size of 0.014 and a power (1-β) of 0.248. Participants’ predicted FAS 
score was equal to 7.880 + .821 (gender) where gender is coded as 0 = 
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males, 1 = females. Participants’ mean FAS score increased by .821 for 
participants who were female.  
A single linear regression was calculated to predict semantic fluency 
(ANT scores) based on education. The regression approached significance 
(F(1,108) 3.422 p=.067), with an R2 of .031 for the effects of education, an f2 
effect size of 0.032 and a power (1-β) of 0.453. Participants’ predicted ANT 
score was equal to 7.500 + 1.410 (education) where education is coded as 0 
= no exams, 1 = educated. Participants’ mean ANT score increased by 
1.410 for participants who were educated.  
Associations between verbal fluency and cognitive factors 
Single linear regressions were calculated to predict phonemic fluency 
(FAS scores) and semantic fluency (ANT) based on semantic memory (GNT 
scores). A significant regression equation was found for phonemic fluency 
and semantic memory (F(1,115)13.702, p=.000), with an R2 of .106, an f2 
effect size of 0.119 and a power (1-β) of 0.956. Participants’ predicted FAS 
score was equal to 3.996 + 0.223 (GNT) points. Participants’ FAS score 
increased by .223 for each point of increase on the GNT. A significant 
regression equation was also found for semantic fluency and semantic 
memory (F(1,115) 20.523, p=.000), with an R2 of .151, an f2 effect size of 
0.178 and a power (1-β) of 0.994. Participants’ predicted ANT score was 
equal to 3.001 + .282 (GNT) points. Participants’ ANT score increased by 
.282 for each point of increase on the GNT.  
A single linear regression was calculated to predict phonemic fluency 
(FAS scores) based on premorbid functioning (TOPF scores). Phonemic 
fluency and premorbid functioning were significantly correlated 
(F(1,108)14.106, p=.000), with an R2 of .109 for the effects of premorbid 
functioning, an f2 effect size of 0.122 and a power (1-β) of 0.961. 
Participants’ predicted FAS score was equal to 4.717 + 0.091 (TOPF) points. 
Participants’ FAS score increased by .091 for each point of increase on the 
TOPF. 
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Associations between verbal fluency and tumour factors 
A single linear regression was calculated to predict phonemic fluency 
(FAS scores) based on tumour type. Phonemic fluency and tumour type 
were not significantly correlated (F(1,102) .428, p=.514), with an R2 of .004 
for the effects of tumour type, an f2 effect size of 0.004 and a power (1-β) of 
0.097. Participants’ predicted FAS score was equal to 7.880 + .821 (tumour 
type) where tumour type was coded as 1 = meningioma, 2 = glioma. 
Participants’ mean FAS score increased by .545 for participants with 
meningioma in comparison to those with glioma. There were no hypotheses 
based on tumour factors and semantic fluency. 
Associations between verbal fluency and mood factors 
Single linear regressions were calculated to predict phonemic fluency 
(FAS scores) and semantic fluency (ANT scores) based on depression 
(HADS-D) and anxiety (HADS-A). The regression outcomes for phonemic 
fluency and depression approached significance (F(1,115) 3.857, p=.052), 
with an R2 of .032 for the effects of depression, an f2 effect size of 0.033 and 
a power (1-β) of 0.489. Participants’ predicted FAS score was equal to 8.792 
- 1.292 (depression) where depression was coded as 0 = not depressed, 1 = 
depressed. Participants’ mean FAS score decreased by 1.292 for 
participants who were coded as depressed in comparison to those who were 
not. Phonemic fluency and anxiety were not significantly correlated (F(1,115) 
.019, p=.890), with an R2 of .000 for the effects of anxiety, an f2 effect size of 
0.033 and a power (1-β) of 0.489. Participants’ predicted FAS score was 
equal to 8.302 + .089 (anxiety) where anxiety was coded as 0 = ‘not 
anxious’, 1 = ‘anxious’. Participants’ mean FAS score increased by .089 for 
participants who were anxious in comparison to those who were not. 
The single linear regression calculated to predict semantic fluency 
(ANT) based on depression (HADS-D) approached significance (F(1,115) 
3.249, p=.074), with an R2 of .027 for the effects of depression, an f2 effect 
size of 0.370 and a power (1-β) of 0.999. Participants’ predicted ANT score 
was equal to 8.935 - 1.260 (depression) where depression was coded as 0 = 
not depressed, 1 = depressed. Participants’ mean ANT score decreased by 
1.260 for participants who were coded as depressed in comparison to those 
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who were not. Semantic fluency and anxiety were not significantly correlated 
(F(1,115) .461, p=.498), with an R2 of .004 for the effects of anxiety, an f2 
effect size of 0.004 and a power (1-β) of 0.103. Participants’ predicted ANT 
score was equal to 8.755 - .458 (anxiety) where anxiety was coded as 0 = 
‘not anxious’, 1 = ‘anxious’. Participants’ mean ANT score increased by -.458 
for participants who were anxious in comparison to those who were not. 
Associations between verbal fluency and localisation  
A multiple regression was calculated to predict phonemic fluency 
based on localisation, with Left Frontal being the reference condition. A 
significant regression equation was found (F(5,85)3.552, p=.006), with an R2 
of .173, an f2 effect size of 0.209 and a power (1-β) of 0.924 for the effects of 
localisation. The predicted FAS score for participants with tumours situated 
in the left frontal lobe was equal to 7.568 (CI 6.575-8.526) given that the 
other localisation areas take the value of zero. Predicted FAS score 
increased by an additional 2.307 points, on average, if the tumour was in the 
right frontal lobe, or 3.098 points if the tumour was in the right parietal lobe 
compared with the results for the left frontal lobe. These relationships were 
shown to be significant (p = .007 and p = .035 respectively). A similar 
relationship was seen in participants who have tumours in the frontal area, 
showing an increase of 1.932, but this was not significantly different to the 
results for left frontal lobe (p = .184). Predicted FAS score decreased by an 
additional 2.318 points if the tumour was in the left parietal lobe, and 1.425 
points if the tumour was in the left temporal lobe. These relationships were 
not significant (p = .184 and p = .294 respectively). 
Table 6. Predictor coefficients for linear regression analyses predicting 
FAS scores for participants with tumours in different localisations 
 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error β 
 (Constant) 7.568 .500  15.146 .000 
Frontal 1.932 1.442 .136 1.339 .184 
Left Parietal -2.318 1.731 -.135 -1.339 .184 
Left temporal -1.425 1.349 -.108 -1.057 .294 
Right Frontal 2.307 .841 .289 2.743 .007 
Right Parietal 3.098 1.442 .218 2.148 .035 
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A multiple regression was calculated to predict semantic fluency 
based on localisation, with Left Frontal being the reference condition. The 
results highlight that the regression equation was not significant (F(5,79) 
.932, p=.465), with an R2 of .056, an f2 effect size of 0.059 and a power (1-β) 
of 0.342 for the effects of localisation. The coefficients are summarised in 
table 7. 
Table 7. Predictor coefficients for linear regression analyses predicting 
ANT scores for participants with tumours in different localisations 
 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error β 
 (Constant) 8.167 .582  14.040 .000 
Frontal 1.833 1.783 .115 1.028 .307 
Left Parietal .083 1.973 .005 .042 .966 
Left Temporal -.738 1.539 -.054 -.480 .633 
Right Frontal 1.786 1.007 .206 1.772 .080 
Right Parietal .167 1.645 .011 .101 .920 
False discovery rate control 
Due to the multiple comparisons conducted throughout the individual 
variable linear regression analyses a correction was required to account for 
the potential false discovery rate. The Benjamini-Hochberg Procedure 
(Benjamini & Hochberg, 1995) was applied to the P values calculated for the 
analyses conducted with the FAS (see table 8) and ANT (see table 9). 
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Table 8. Benjamini-Hochberg outcomes for FAS analyses 
Variable 
correlated  
with FAS 
Original P-
values  
Benjamini-
Hochberg P-
values 
Benjamini-Hochberg 
significance  
(0.1 error rate) 
TOPF 0 0 significant 
GNT 0 0 significant 
Left Frontal 0 0 significant 
Education 0.007 0.018 significant 
Right Frontal 0.007 0.018 significant 
Right Parietal 0.035 0.076 significant 
HADS-D 0.052 0.097 significant 
Frontal 0.184 0.26 not significant 
Left Parietal 0.184 0.26 not significant 
Gender 0.2 0.26 not significant 
Left Temporal 0.294 0.347 not significant 
Tumour type 0.514 0.557 not significant 
HADS-A 0.89 0.89 not significant 
 
After controlling for the error rate using the Benjamini-Hochberg Procedure 
(Benjamini & Hochberg, 1995) on the analyses conducted for the FAS the 
significance of the HADS-D correlation changed from not significant (at an α 
level of .05) to significant (at an error rate of 0.1). While most of the other 
variables had altered values, they all remained significant or non-significant 
in line with the significance outcome of the original value.  
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Table 9. Benjamini-Hochberg outcomes for ANT analyses 
Variable 
correlated  
with ANT 
Original P-
values  
Benjamini-
Hochberg P-
values 
Benjamini-Hochberg 
significance  
(0.1 error rate) 
GNT 0 0 significant 
Left Frontal 0 0 significant 
Education 0.067 0.16 not significant 
HADS-D 0.074 0.16 not significant 
Right Fontal 0.08 0.16 not significant 
Frontal 0.307 0.512 not significant 
HADS-A 0.498 0.711 not significant 
Left Temporal 0.633 0.791 not significant 
Right Parietal 0.92 0.966 not significant 
Left Parietal 0.966 0.966 not significant 
 
After controlling for the error rate using the Benjamini-Hochberg Procedure 
(Benjamini & Hochberg, 1995) on the analyses conducted for the ANT all 
variables remained significant or non-significant in line with the significance 
outcome of the original value.  
 
Further analyses with phonemic fluency 
Hierarchical regression analyses were performed to assess the value 
of associations between the predictor variables gender, education, tumour 
type, depression, semantic memory, and premorbid functioning on the 
relationship between localisation and phonemic fluency. Localisation (with 
Left Fontal as the reference category) was entered into the first stage of the 
analysis (block one) to allow for comparison of the effects of the other 
variables during each stage of the model. Localisation predicted 17.2% of 
the variance in phonemic fluency scores. The predictor variables (gender, 
education, tumour type, depression, semantic memory, and premorbid 
functioning) were added to the second stage of the analysis (block 2). 
Following the additions in block 2 the total variance explained by the model 
was 47%, F (6, 68) 6.394, p = 0.000. This means that the predictor variables 
(gender, education, tumour type, depression, semantic memory, and 
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premorbid functioning) explained an additional 29.9% of the variance in 
phonemic fluency scores after localisation had been accounted for. In model 
2 there were statistically significant relationships between FAS and a 
number of the predictors added after localisation. Gender (β = .228, p = 
.030) and education (β =.192, p = .047) were statistically significant 
demographic predictors. Depression (β = -.200, p = .034) and GNT (β = 
.274, p = .012) were statistically significant psychometric/neuropsychological 
assessment predictors. The TOPF score variable approached significance (β 
= .197, p = .077). Table 10 summarises the predictor coefficients for this 
analysis. 
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Table 10. Predictor coefficients for hierarchical multiple regression 
analyses predicting FAS scores 
Model 
Unstandardized 
Coefficients Standardized Coefficients 
B 
Std. 
Error Beta t 
 
Sig. 
1 (Constant) 7.718 .543  14.216 .000 
Frontal 1.082 1.610 .073 .672 .504 
Left Parietal -2.468 1.780 -.150 -1.387 .170 
Left Temporal -1.575 1.392 -.124 -1.132 .261 
Right Frontal 2.335 .949 .277 2.461 .016 
Right Parietal 2.949 1.487 .217 1.983 .051 
2 (Constant) -.845 1.917  -.441 .661 
Frontal .817 1.381 .055 .592 .556 
Left Parietal -1.067 1.559 -.065 -.684 .496 
Left Temporal .267 1.308 .021 .204 .839 
Right Frontal 2.123 .803 .252 2.642 .010 
Right Parietal 3.721 1.294 .274 2.877 .005 
TOPF .055 .031 .197 1.796 .077 
GNT .192 .074 .274 2.576 .012 
Depressed -1.473 .679 -.200 -2.169 .034 
Gender 1.636 .740 .228 2.210 .030 
Education 1.518 .749 .192 2.027 .047 
Tumour type .870 .909 .099 .957 .342 
 
Post hoc power analysis of phonemic fluency hierarchical 
regression 
G*Power (Faul et al., 2009) was used to calculate a post hoc analysis 
for a multiple regression with eleven predictors, an alpha value of .05, a 
sample size of 80 and an f2effect size of 0.887 as calculated using the R2 
value provided in the analysis results (0.47). This calculation indicated that 
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the power achieved in this analysis was 0.99, which is a very high power 
score, indicating that the likelihood of the results being due to a type 2 error 
are very low. 
Further analyses with semantic fluency 
Hierarchical regression analyses were performed to assess the value 
of associations between the predictor variables education, depression, and 
semantic memory on the relationship between localisation (with Left Frontal 
as the reference condition) and semantic fluency. Localisation was entered 
into the first stage of the analysis (block one) to allow for comparison of the 
effects of the other variables during each stage of the model. Localisation 
did not predict variance in semantic fluency scores (F(5,79) .932, p=.465), 
with an R2 of .056. The predictor variables (education, depression, and 
semantic memory) were added to the second stage of the analysis (block 2). 
Following the additions in block 2 the total variance explained by the model 
was 24%, F (3, 76) 6.158, p = 0.001. This means that the predictor variables 
(education, depression, and semantic memory) explained an additional 
18.5% of the variance in semantic fluency scores after localisation had been 
accounted for. In model 2 there was a statistically significant relationship 
between ANT and GNT (β = .360, p = .001). The association between ANT 
and depression approached significance (β = -.176, p = .086). Table 11 
summarises the predictor coefficients for this analysis. 
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Table 11. Predictor coefficients for hierarchical multiple regression 
analyses predicting ANT scores 
Model 
Unstandardized 
Coefficients Standardized Coefficients 
B 
Std. 
Error Beta t 
 
Sig. 
1 (Constant) 8.167 .582  14.040 .000 
Frontal 1.833 1.783 .115 1.028 .307 
Left Parietal .083 1.973 .005 .042 .966 
Left Temporal -.738 1.539 -.054 -.480 .633 
Right Frontal 1.786 1.007 .206 1.772 .080 
Right Parietal .167 1.645 .011 .101 .920 
2 (Constant) 2.414 1.767  1.366 .176 
Frontal .912 1.649 .057 .553 .582 
Left Parietal 1.059 1.836 .060 .577 .566 
Left Temporal .828 1.465 .061 .565 .574 
Right Frontal 1.475 .928 .170 1.589 .116 
Right Parietal .312 1.513 .021 .207 .837 
GNT .269 .079 .360 3.397 .001 
Depressed -1.366 .784 -.176 -1.742 .086 
Education 1.349 .873 .160 1.545 .126 
 
Post hoc power analysis of semantic fluency hierarchical 
regression 
G*Power (Faul et al., 2009) was used to calculate a post hoc analysis 
for a multiple regression with eleven predictors, an alpha value of .05, a 
sample size of 85 and an f2effect size of 0.316 as calculated using the R2 
value provided in the analysis results (0.240). This calculation indicated that 
the power achieved in this analysis was 0.994, which is a very high power 
score, indicating that the likelihood of the results being due to a type 2 error 
is very low. 
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Summary of results  
An increase in phonemic fluency was significantly correlated with 
being educated (F(1,115) 7.639 p=.007; R2 = .066), an increase in semantic 
memory (F(1,115)13.702, p=.000; R2 = .106), and an increase in premorbid 
functioning (F(1,108)14.106, p=.000; R2 = .109). Phonemic fluency was 
significantly correlated with localisation (F(5,85)3.552, p=.006; R2 = .173). 
More specifically, an increase in phonemic fluency was significantly 
associated with tumours in the right frontal and right parietal lobes (p = .007 
and p = .035 respectively) in comparison to the left frontal lobe. Phonemic 
fluency was not significantly correlated with depression (F(1,115) 3.857, 
p=.052; R2 = .032) in the original regression analysis, however when the 
Benjamini-Hochberg Procedure was applied to account for the false 
discovery rate phonemic fluency was significantly correlated with depression 
(0.097; using an error rate of 0.1).  
An increase in semantic fluency was correlated with an increase in 
semantic memory (F(1,115) 20.523, p=.000; R2 = .151). 
Phonemic fluency was not significantly correlated with gender 
(F(1,115) 1.664 p=.200; R2 = .014), tumour type (F(1,102) .428, p=.514; R2 = 
.004), or anxiety (F(1,115) .019, p=.890; R2 = .000). Neither was phonemic 
fluency significantly correlated with tumours situated in the frontal lobe (p = 
.184), left parietal lobe (p = .184), or the left temporal lobe (p = .294) in 
comparison to the left frontal lobe.  
Semantic fluency was not correlated with education (F(1,108) 3.422 
p=.067; R2 = .031), or depression (F(1,115) 3.249, p=.074; R2 = .027), 
however, there were trends indicating that an increase in semantic fluency 
was associated with being educated and a decrease in depression scores. 
Semantic fluency was not correlated with anxiety (F(1,115) .461, p=.498; R2 
= .004) or localisation (F(5,79) .932, p=.465; R2 = .056). 
Discussion 
This chapter summarises the above results and discusses the 
hypotheses tested, evaluating the strengths and limitations of the study in 
relation to the current literature. The clinical utility of the results will be 
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considered and suggestions for future studies provided. This section will 
begin with a summary of the findings and then discuss the findings for each 
area of interest (demographic factors, cognitive factors, tumour factors, 
mood factors and localisation) in more detail. Following the discussion about 
the outcomes this section will go on to consider the strengths and 
weaknesses of this study, concluding with reflections on the clinical 
implications of these outcomes and suggestions for future research. 
Summary of findings 
Poorer performance in phonemic fluency was significantly correlated 
with not completing educational exams, higher levels of depression and 
poorer performance in semantic memory and premorbid functioning. 
Phonemic fluency was also significantly correlated with localisation. More 
specifically, a decrease in phonemic fluency was significantly associated 
with tumours in the left frontal lobe in comparison to right frontal and right 
parietal lobes which were associated with an increase in performance in this 
function. Poorer performance in semantic fluency was correlated with poorer 
performance in semantic memory.  
Phonemic fluency was not significantly correlated with gender, tumour 
type, or anxiety. Neither was phonemic fluency significantly correlated with 
tumours situated in the frontal lobe, left parietal lobe, or the left temporal 
lobe, in comparison to the left frontal lobe. Semantic fluency was not 
correlated with anxiety or localisation. Neither was semantic fluency 
correlated with education or depression, although, there were trends 
indicating that an increase in semantic fluency performance was associated 
with completing educational exams. 
The outcomes from the hierarchical multiple regressions indicated 
that localisation, gender, education, tumour type, depression, semantic 
memory, and premorbid functioning, when combined, can predict phonemic 
fluency variance. Localisation, semantic memory, depression and education 
do not predict semantic fluency, as within this model the only significant 
relationship was between semantic memory and semantic fluency (which 
mimics the outcomes of the simple linear analyses conducted for semantic 
fluency). 
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Demographic factors and verbal fluency 
It was hypothesised that higher levels of education would have a 
positive association with both phonemic and semantic fluency. The findings 
indicate that there was a significantly positive association between education 
and phonemic fluency, but not for education and semantic fluency. There 
was a trend towards having an education being positively associated with 
semantic fluency, but unfortunately the analysis lacked both power and 
effect, meaning that more research would be warranted in this area. While 
there was a lack of significant results for semantic fluency and education, the 
trends in these results did point towards a positive relationship between 
being educated and an increase in semantic fluency. This combined with the 
significant results for phonemic fluency support a number of other papers 
who were able to conduct analyses with higher levels of power to find 
positive relationships between levels of education and an increase in 
performance of semantic and phonemic fluency, (e.g. Gladsjo et al., 1999 
and Loonstra et al., 2001). More specifically, the study by Gladsjo et al., 
(1991) found these significant results with a non-clinical population of 768 
adults, using number of years in education as the measurement for this 
variable, and the same measures for phonemic and semantic fluency used 
in this study (FAS and ANT). The analysis they conducted was therefore 
likely to have considerably more power to detect an effect and the use of a 
continuous variable for education would have likely yielded richer results. It 
could be assumed that if this study were able to be replicated with an 
increased number of participants (and perhaps measuring education in a 
more meaningful way) it may be possible to detect significant results for 
associations between semantic fluency and education. 
It was also hypothesised that being female would have a positive 
association with phonemic fluency based on the meta-analysis conducted by 
Loonstra et al., (2001). Conversely, the results for the analysis of phonemic 
fluency and gender in this study were not significant, in line with the 
outcomes of a number of earlier studies looking at this association, such as 
Riva, Nichelli, & Devoti, (2000) and Tombaugh et al., (1999). However, the 
reason the hypothesis for this study was focused on the results found by 
Loonstra et al., (2001) was because they used these initial studies within 
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their meta-analysis to find significant correlations when combining the 
papers (to increase the power of the analysis). Despite our hope of having 
an increased power in this study’s analysis, for this association there was 
actually low power in the outcome (0.453). It is therefore possible that further 
research in this area utilising a higher powered analysis may bring to light 
detectable significant correlations. This idea is further supported by the 
outcomes from the hierarchical multiple linear regression which 
demonstrated a significant relationship between gender and phonemic 
fluency when localisation effects had been accounted for and the other 
variables had been entered alongside gender to heighten the power of the 
analysis and absorb some of the residual variance of the phonemic fluency 
scores. 
Cognitive factors and verbal fluency 
It was hypothesised that higher scores in semantic memory would be 
positively associated with both phonemic and semantic fluency. The results 
significantly support both of these hypotheses and the findings previously 
documented by Henry, Crawford, & Phillips, (2004) and Riva et al., (2000). 
This is a useful addition to the evidence base as it is the first study to look 
more specifically at correlations with both types of verbal fluency and 
semantic memory using the GNT as opposed to the BNT, which allows 
some generalisation of the relationship between semantic memory as a 
concept as opposed to a relationship with one specific test.  
It was also hypothesised that higher scores in premorbid functioning 
would be positively associated with phonemic fluency. This hypothesis was 
supported by significant results. Previous studies showing correlations of 
these skills have used more dated tests of premorbid functioning, such as 
the NART (Bird, Papadopoulou, Ricciardelli, Rossor, & Cipolotti, 2004; 
Crawford et al., 1992; Ross, 2003) and the WIAT-II (Davis et al., 2017). The 
results from this study are therefore particularly important, as the TOPF is 
currently considered a core component in most neurocognitive batteries, 
whereas the NART and WIAT-II are comparatively outdated.  
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Tumour factors and verbal fluency 
It was hypothesised that there would be a difference in association 
between phonemic fluency and tumour type. The results of this study do not 
support this hypothesis. It is difficult to compare this outcome to the results 
from the only related study available that included the effects of tumour type 
and a measure of phonemic fluency functioning (Hahn et al., 2003). This is 
because the study by Hahn et al., (2003) did not discuss the specific types of 
tumour assessed against the main tumour group (glioblastoma multiforme). 
Additionally, glioblastoma multiforme was not a tumour type this study was 
able to focus on (as this study did not have enough data to breakdown the 
variables into groups outside of glioma and meningioma). The results of this 
study are therefore more in line with the results found in the few studies 
looking more generally at cognitive functioning and tumour type, where no 
significant associations were found (Hoffermann et al., 2017; Hom & Reitan, 
1984; Kayl & Meyers, 2003; Scheibel et al., 1996). It is also worth noting that 
the power within this analysis of tumour types and fluency was very low, 
meaning that the chances for a type 2 error was quite high and so further 
research in this area would be warranted. There were no hypotheses for 
tumour type related to semantic fluency. 
It is important to note that, due to a lack of data on tumour size this 
study was unable to account for this variable in this analysis. As it has been 
highlighted that increased tumour size is likely to have a greater association 
with performance deficits than the type of tumour (Kayl & Meyers, 2003), it is 
possible that this unmeasured variable could have moderated the effects 
found for type of tumour in this study.  
Mood factors and verbal fluency 
It was hypothesised that increased levels of depression would be 
associated with poorer performances in both phonemic and semantic 
fluency, but that anxiety would not affect either form of verbal fluency. 
Phonemic fluency showed a significant negative association with depression 
(once the false discovery rate was controlled for), which was further 
supported by the significant association found between these variables when 
they were entered into the hierarchical multiple regression.  
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There was not a significant relationship between semantic fluency 
and depression. The discrepancy in this result is surprising, as the outcome 
of this relationship is in opposition to the majority of outcomes found to date 
between these two variables (Brown et al., 1994; Christensen et al., 1997; 
Fossati et al., 1999; Henry & Crawford, 2005; Trichard et al., 1995; Yochim 
et al., 2013). This is particularly surprising in light of the result being 
accompanied by a strong effect size and a high level of power, indicating 
that the lack of significance was less likely to be due to a type 2 error. It is 
therefore important to consider the wider influences to this outcome. One 
factor to reflect on would be that some assessment tools are significantly 
more sensitive when used with brain tumour patients than others, meaning 
that variability below a certain baseline within some tests may not be 
detected (Hom & Reitan, 1984; Archibald, Lunn & Ruttan et al., 1994). This 
difficulty is partly in relation to the population norms used to detect clinical 
difficulties and is most likely to create issues if used in relation to a ‘cut-off’ of 
clinical caseness/neurological deficit. Similarly, it is advisable to use 
population specific norms to measure outcomes in clinical populations. A 
specific cut-off was not used for the ANT data, but while the test was not 
specifically normed to the brain tumour population it was designed in the first 
instance as a means of measuring neurological deficit for a range of 
neurological difficulties which may impact verbal communication skills.  
The HADS was used to measure depression and the norms for this 
test were not derived from a population of individuals with brain tumour. 
However, this test was designed specifically for populations of individuals 
with health conditions (including cancer) with the aim of accounting for 
physical/somatosensory symptoms which can be confused/overlap with 
symptoms attributed to mood effects. This measure had therefore been 
chosen as the best option for capturing mood effects in this population. A 
similar consideration is that converting a continuous variable into a 
dichotomous variable in this way (caseness versus no caseness) can make 
the results more clinically meaningful. However, it is also worth noting that 
this approach to manipulating the data will have reduced the richness of the 
data available on depression, possibly reducing the effect size. It would be 
worth following these contradictory results up with a study using a richer 
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array of mood data designed more specifically for the brain tumour 
population.   
Other factors that may have had an influence on these controversial 
outcomes could include effects specific to this sample of individuals with 
brain tumour. One key factor to consider is the distribution of scores for the 
measures used (ANT and the HADS-D). During the assessment of normality 
the HADS-D stood out as a variable that required further consideration. The 
frequency division between the caseness criteria (depressed v not 
depressed) included only 43 (35%) participants having scores meeting the 
criteria for depression. As can be seen in Figure 2, when assessing the 
distribution of the HADS-D it stood out from the other variables in that it was 
slightly positively skewed, with a leptokurtic tail particularly to the left of the 
graph. While a normal distribution would still expect to see fewer data points 
in the extremities of the bell curve, this sample had considerably fewer than 
would be expected in an ideal distribution and there was a heavier weighting 
of participants with lower depression scores. More specifically, when the 
frequency distribution of the raw scores are considered in more detail (see 
Appendix D) it becomes apparent that, from the 43 (35%) participants in the 
depressed group, the sample is heavily weighted in the lower scores 
(between 8 and 11) with only 13 people (7.3%) scoring between 12 and 20 
(indicating higher levels of depression). It is suggested by the author of the 
HADS that moderate cases of depression (or anxiety) should fall between 11 
and 15, and that severe cases should fall above this range (Zigmond & 
Snaith, 1983). While our cut-off criteria were chosen to be more inclusive to 
a range of levels of depression, it makes sense that stronger effects of 
depression would be found in a sample of individuals with higher levels of 
depression (e.g. in the ‘severe’ range/16+). There were only 2 individuals 
(1.6%) in this current sample who met this ‘severe’ criteria, and as described 
above, not many participants fell in the moderate range either. It is therefore 
possible that the lower levels of depression among this study’s population 
sample reduced the effects available to detect in this analysis. A similar 
design using a sample including a more balanced frequency of participants 
with higher levels of depression could possibly bring to light significant 
relationships between semantic fluency and depression.  
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Anxiety was investigated as an exploratory variable. The results 
indicate that it is not associated with either form of verbal fluency. This is in 
line with the limited range of previous studies looking into associations with 
anxiety and verbal fluency (Airaksinen et al., 2005; Talacchi et al., 2011; 
Yochim et al., 2013) and so could be assumed to be an accurate 
representation of the relationship. However, as has been discussed above, 
some variables have shown non-significant associations in individual 
studies, but then highlighted significant associations when combined in a 
meta-analysis, producing greater power. As the results for anxiety and both 
types of fluency in this study lacked power, the presence of a type 2 error is 
possible, meaning these findings may be similarly worth following up with a 
meta-analysis and/or a study with higher levels of power.   
Localisation of phonemic fluency 
Based on a relatively conclusive range of evidence (Metternich et al., 
2014; Robinson et al., 2012; Szatkowska et al., 2000; Troyer et al., 1997), it 
was hypothesised that poorer performance in phonemic fluency would be 
more strongly associated with participants who had tumours in the left frontal 
lobe than in other areas. More specifically it was hypothesised that tumours 
in the left dorsolateral prefrontal cortex would correlate with poorer phonemic 
fluency performance (Szatkowska et al., 2000; Troyer et al., 1997). 
Unfortunately, at the phase of data coding it became apparent that the 
information in the data set did not allow us to focus on this specific area and 
so inferences could only be drawn at the wider regional area of the left 
frontal lobe, reducing the specificity of the localisation effects in this study.  
The results indicated that tumour location was a significant predictor 
for variance in phonemic fluency scores and that the left frontal localisation 
was strongly associated with variance in phonemic fluency. This result is 
supported by a medium effect size and a high power value, indicating that 
the results are unlikely to be due to a type 2 error. The results also indicate a 
trend in higher scores in phonemic fluency being associated with the frontal, 
right frontal and right parietal areas, indicating that these areas are not 
involved in phonemic fluency performance in comparison to the left frontal 
area. These results are supportive of a general lateralisation effect where 
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phonemic fluency functioning is related to the left side of the brain as 
opposed to the right. These findings are also in line with this study’s 
hypothesis. The association between phonemic fluency and frontal lobe 
tumours was not significant. The association between phonemic fluency and 
right parietal tumours only approached significance (although very closely at 
.051), however, once the effects of the additional predictor variables were 
accounted for in model 2, the effects for the right parietal tumour effects 
became significant (p = .005). People with right frontal tumours were 
significantly associated with higher phonemic fluency scores in comparison 
to people with left frontal tumours in both model 1 and model 2. People with 
tumours in the left parietal and left temporal areas were not significantly 
associated with variance in the FAS scores in comparison to the left frontal 
lobe in either model. They both followed a trend of participants scoring lower 
on phonemic fluency if they had tumours in this area in comparison to those 
that had tumours in the left frontal area. 
When taking into account the localisations which were unable to 
demonstrate significant associations, this analysis provides results that 
indicate that participants with tumours in the left frontal lobe will on average 
score significantly lower in phonemic fluency than participants who have 
tumours in the localisation areas investigated in this study on the right 
cerebral hemisphere (right frontal and right parietal). This is therefore 
supportive of both a left sided lateralisation effect and, in line with the 
assumptions made by modularity models of cognition (Shallice, 1988) infers 
that the left frontal lobe is involved in phonemic fluency functioning. There is 
a trend indicating lower phonemic fluency scores in comparison to the left 
frontal lobe for other areas on the left cerebral hemisphere (left parietal and 
left temporal), however, these results were not significant.  
It is important when interpreting these results to consider the impact 
of sample size in each of the localisation categories. While the regression 
calculation held a high level of power as a whole, this power isn’t directly 
applicable to each individual localisation level due to there being a very 
uneven distribution of participants across each category. The areas where 
significant results were not found all had seven or less participant data sets 
assigned to them. In the areas where there were more data (e.g. left frontal 
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and right frontal) significant associations were more likely to be found. The 
results from areas where there were a very small number of participants are 
therefore less replicable and representative of the population. This naturally 
brings to question the reliability of these results when interpreted as a whole 
‘localisation effect’, because there are clearly differences among the 
localisation groups.  
Localisation of semantic fluency 
It was hypothesised that poorer performance in semantic fluency 
would be associated with patients who have brain tumours in both the left 
frontal lobe, the right frontal lobe or the left temporal lobe. The results show 
that there were no significant effects of localisation on the variance of 
semantic fluency scores. This therefore means that the results found for 
phonemic fluency cannot be further validated with a dissociation model 
(Teuber, 1955) due to the comparison to another subcomponent of verbal 
fluency localisation not being available (however, the more generic 
lateralisation effects and modularity based lesion-behaviour mapping 
reasoning focusing on the left frontal lobe are still valid). 
This result for semantic fluency was surprising, particularly in light of 
the significant results found for phonemic fluency from the same data set. 
However, when power is low (e.g. approximately .50) an inconsistent pattern 
of results may be seen among research in that area, where some results are 
significant and others not (Kazdin & Bass, 1989; Rossi, 1982, 1986, 1990). 
The power for this calculation was small (0.342), indicating that differences 
that may have been present in this sample were unlikely to be detected.  
It could also be hypothesised that due to semantic fluency requiring 
less input from higher order executive functions (McCloskey & Perkins, 
2012), and therefore drawing from a less diverse range of functions, the 
neural correlates of this skill are more precise and so the broad localisation 
categories used within this study were not able to accurately detect the more 
precise areas relevant to that skill. However, this finding is inconsistent with 
previous studies in this area which point to semantic fluency being correlated 
with quite a broad range of localisations (Crowe, 1992; Metternich et al., 
2014; Robinson et al., 2012; Szatkowska et al., 2000; Troyer et al., 1998). 
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Along the same lines it is worth noting that these studies were able to focus 
their neural correlate search on more specific regions within the broader 
range of areas investigated, such as the ‘left dorsolateral and/or lenticular 
striate frontal regions’ (Loonstra et al., 2001) in comparison to the broader 
‘left frontal lobe’ category used in the present study. It would make sense 
that this specificity would reduce the likelihood of dilution of results in 
patients who have lesions in the left frontal lobe (to use this current example) 
but not more specifically in the left dorsolateral and/or lenticular striate 
frontal regions.  
There are also a range of limitations to the design and analysis used 
in this study which may have influenced this study’s ability to find significant 
results in some areas, discussed in more detail below. 
Predicting phonemic fluency 
The hierarchical multiple regression used to analyse the associations 
between gender, education, tumour type, depression, semantic memory, 
and premorbid functioning on the relationship between localisation and 
phonemic fluency demonstrated a good model fit (explaining 47% of the 
variance in total), with localisation predicting 17.2% of the variance in 
phonemic fluency scores; and gender, education, tumour type, depression, 
semantic memory, and premorbid functioning explaining an additional 29.9% 
of the variance in phonemic fluency scores after localisation had been 
accounted for. However, within this model tumour type was not a significant 
predictor. It would have been helpful to have completed a further analysis of 
the strength of this model without the non-significant predictor (tumour type) 
included, so this would be a good point to revisit in future research. 
Predicting semantic fluency 
The inclusion of localisation, semantic memory, depression and 
education as predictor variables for semantic fluency in the hierarchical 
multiple regression highlighted that this model predicted only 18.5% of the 
variance in semantic fluency scores. The only significant relationship within 
this model was between semantic memory and semantic fluency. This 
unsurprisingly mimics the outcomes of the simple linear analyses conducted 
for semantic fluency. 
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Strengths and weaknesses of the study 
Alongside the factors discussed above critiquing more specific 
elements of the study in relation to the outcomes, this study will be evaluated 
in light of four criteria, test administration and standardisation, recruitment 
and participation, study design and statistical analysis. The study discussion 
will then be summarised and concluded with a focus on the clinical utility of 
the results and recommendations for future research.  
Test administration and standardisation 
Standardisation (in relation to the administration of the assessment) 
refers to the likelihood of variations in how the test is administered to each 
participant. Changes in administration such as frequency of prompting, 
accuracy in timing, and more subtle aspects such as intonation in the 
delivery of instructions can have an effect on the patient’s performance. All 
the tests used in this study were administered by highly trained clinicians 
which reduces the chance of variation in test delivery and supports the 
likelihood that administration was conducted appropriately. Along with the 
skills of the administrator, the guidance provided by the test developer can 
also influence the likelihood of standardisation of administration. The 
assessment tools used varied in the level of instruction provided with the test 
equipment to guide both administration and scoring of the assessment. The 
TOPF for example is a test with a clear instruction manual, clear instructions 
on how to respond to participants seeking further guidance, and significant 
support in scoring and interpreting the outcomes (such as a cd with an audio 
recording of the accepted phonemic expressions to guide scoring). This 
leaves limited room for the influence of subjective bias in delivery and 
interpretation. The HADS on the other hand is a measure which is naturally 
subjective in interpretation by the respondent (relying on a Likert scale of 
experiences), which can often lead to the participant feeling unsure about 
how to answer and seeking further guidance from the administrator. Further 
guidance instructions are minimal, leaving a wider range of decisions on how 
to respond to the participant and deliver the assessment up to the assessor. 
Therefore, it is important to consider that while the administrators were 
highly trained, some of the tests used (particularly the mood measure) 
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require a level of caution in interpretation of the outcomes due to the 
subjective nature of the responses. This is not unusual in tests of mood, as 
the construct of mood in itself is a subjective state.   
Along similar lines, one of the key difficulties in the evidence base to 
date is the vast range of tests available claiming to measure the same 
symptoms/skills, which are inconsistently used among researchers (van 
Loon et al., 2015), and to some degree clinicians. This lack of consensus 
created some difficulty in selecting variables in the first place, based on 
previous research. The clearest example of this was when considering the 
test of semantic memory, as the data in this study was based on the use of 
the GNT, however, the (very few) studies used in previous research looking 
at the relationships between semantic memory and verbal fluency used the 
BNT. While these tests are very similar, it is difficult to draw reliable and 
valid conclusions on the effects found across two different tests in this 
fashion. Equally, these results require similar caution when being used 
within the clinical population to consider the predictions of verbal fluency in 
patients who have competed tests of semantic memory other than the GNT. 
This understandably limits the clinical utility of this work and further research 
comparing semantic fluency (or any of the other cognitive skills reported in 
this study) among different test outcomes would enhance this deficit.  
Recruitment and participation 
The participant data was provided solely from the neuro-oncology 
department within the Medical Psychology Team at James Cook University 
Hospital (under South Tees Hospitals NHS Foundation Trust). Due to the 
data being provided by the service consisting of information routinely 
collected as part of their service evaluation data, patient consent specific to 
this study was not required. This means that there was no bias created by 
participant interest in the topic area, increasing the representativeness of the 
study sample. However, due to the data coming from one service, the 
representativeness of the population only expands to neuro-oncology 
patients within the areas of County Durham, Teesside, Darlington, and North 
Yorkshire, between the ages of 22 and 90, and more specifically with 
gliomas or meningiomas. It would be fair to assume the geographic location 
- 97 - 
of the participants was generalisable to rest of the UK population, however, 
as more precise population factors were not measured (such as ethnicity, 
religion, sexuality or occupation) this cannot be explicitly stated.  
Study design  
This research project is novel in the literature focusing on neural 
correlates of verbal fluency due to its design being inclusive of a wider range 
of factors (i.e. mood effects, tumour effects, cognitive measures, and 
demographics) than similar studies preceding it. This means that it has been 
able to more reliably and inclusively explore the associations between verbal 
fluency performance and localisation in patients with brain tumour. This 
study has also played a role in developing a very sparse evidence base 
around factors which may affect this important and clinically instrumental 
skill. More specifically the novelty and utility of this study was further 
enhanced by the inclusion of a test of premorbid functioning (TOPF), 
semantic memory (GNT) and a measure of depression which was designed 
specifically to be more reliable and valid for populations with health 
conditions.  
This study used a cross-sectional design meaning all the data was 
collected in one respective time point. Similarly this study is limited to the 
use of ‘attribute variables’ which limits the types of conclusion and 
inferences which can be drawn from this study (Tupper & Rosenblood, 
1984). Due to these design factors causality cannot be determined and 
fluctuations in results over time could not be investigated. A study with a 
longitudinal design and ‘active’ variables would enhance our understanding 
of the findings in this project (Tupper & Rosenblood, 1984). 
The variables list was chosen based on indications of effect (or a lack 
of consistency in effect) from the evidence base on and around the topics of 
interest. This is a standard scientific approach to take when designing 
studies, particularly those focused on a wide range of potential influential 
variables. However, it does limit the investigations to an already narrowed 
range, excluding investigation into a wider range of potentially influential 
effects which could have improved the predictive power of the proposed 
model. Of similar relevance, due to the population of interest being ‘self-
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selected’ based on a commonality of certain attributes (having a brain 
tumour), random assignment of variables within the study is not an option. 
Due to this any differences seen between variables of interest cannot be 
solely attributed to that variable as the differences could have occurred due 
to a different extraneous variable confounded with the variable of interest. 
Another design difficulty related to the lack of assignment control in 
this approach is the occurrence of unequal numbers of participants in 
different categories/cells, for example, within localisation, 37.6% of 
participants had tumours in the left frontal area and 4.4% of participants had 
tumours in the left parietal area. This means that it is harder to detect the 
effects within the categories with lower numbers of participants (e.g. left 
parietal), and that the power results measured from the equation as a whole 
(e.g. the effects of localisation and fluency) becomes less applicable. This 
has been discussed in more detail in the results section. 
One specific weakness of the study is that it did not account for age 
effects. The evidence base has highlighted that there are clear links between 
age and verbal fluency performance, with phonemic and semantic fluency 
both tending to improve during childhood, peaking when an individual 
reaches their thirties, and declining in old age (Delis et al., 2001a; 
Tombaugh et al., 1999). It was decided when designing the study that 
including the age of the participants would be less clinically meaningful as it 
doesn’t take into account the fact that age effects would become nullified at 
the point verbal fluency is impacted by the presence of the tumour. This 
study did not have information on the date of diagnosis, which may have 
given a closer insight into these effects. However, even if this study had 
been able to acquire this information, it still would not necessarily be 
representing the date the tumour itself was formed, or the date the tumour 
started to impact on functioning. This study therefore was designed in the 
most clinically relevant way to measure the effects most likely to be relevant 
to verbal fluency performance, meaning that age effects were not part of the 
factors measured.   
During the design phase it was felt important to include the data for 
tumours labelled as ‘frontal’ in the data set (meaning they could be 
- 99 - 
positioned in either frontal lobe, but data wasn’t available to specify which). 
This decision was made due to the influence these tumours may have had if 
both left and right frontal tumours were associated with one of the forms of 
fluency, and for the purpose of retaining as much data as possible. However, 
retrospectively this can be considered as a design flaw. It makes sense in 
this analysis that the results for ‘frontal’ were weak in effect due to the fact 
that the frontal tumours spanned both the left and the right lobes, and may 
well have impacted either area, or both areas simultaneously. It was not 
possible to define these regions from the data provided by the service. Due 
to this, in the event where only the left frontal lobe, or only the right frontal 
lobe were implicated in fluency function any effects created by tumours 
impacting the left frontal area (within the ‘frontal’ group) were possibly diluted 
by data included that impacted only the right frontal area (again, within the 
‘frontal’ group), leading to a lack of significance, and meaning, behind the 
outcomes for this area. Given the results from this study and results from 
previous studies, this was more likely to be the case with phonemic fluency 
as it was not associated with the right frontal lobe, but strongly associated 
with the left frontal lobe. 
There are methodological drawbacks to using lesion-behaviour 
mapping approaches. Some of these common drawbacks were overcome by 
the design of this study, for example many studies only focus on participants 
with deficits in the function of interest, not including participants who perform 
well in the function (Rorden & Karnath, 2004). Despite this inferences are 
still often made about the neural areas which are not impaired functioning 
adequately, which is not a reliable inference to make (Farah, 1994). This 
study sought to include participants with a range of performance levels in the 
cognitions measured and included localisations covering large regions of the 
cortex, including areas which were not of primary focus. This study therefore 
demonstrate methodological strength in this remit.  
However, there are still some limitations to this study that were 
unavoidable in relation to the underlying theories used in lesion-behaviour 
mapping. Of particular relevance is the assumption of modularity (Shallice, 
1988) in what is a form of executive function. Executive functions are 
commonly considered higher order due to their nature of integrating a range 
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of skills (such as memory and language) while promoting cognitive flexibility 
and problem solving (Della Sala et al., 1998). It would make sense that skills 
of this nature are ever more likely to involve functions carried out in a 
distributed manner, with larger regions of the brain working together in a 
more fluid/plastic state (Farah, 1994). With this reasoning in mind, 
incorporating methods that allow the monitoring of processes over time 
(including aspects of feedback between neural areas) would be highly 
beneficial. An example of this would be to use scanning methods such as 
fMRI to further support the outcomes found in this study. Unfortunately this 
approach was beyond the remit of this piece of research.  
Using patients with brain tumour also has implications for the 
outcomes as there are often effects of neural pressure caused by oedema 
that can impact functioning more broadly around the tumour location. Again 
using method relying on technologies such as fMRI scanning would have 
allowed investigations of neural-behavioural associations in neurologically 
healthy individuals which would complement the results found in this lesion-
behaviour mapping study.  
Statistical analysis 
Data from 123 participants were initially included in the study, with 80 
participants being included within the final hierarchical analyses looking 
more inclusively at all the relevant variables. This is a sample size which 
was considered to provide excellent power (up to 0.99) for the multiple 
regression analyses conducted. As discussed in the literature review, due to 
the rarity of the neurological conditions of interest (in localisation studies 
more generally, and studies with patients with brain tumour more 
specifically), very few studies have been conducted which match or exceed 
this level of power, with many not even being able to conduct statistical 
analyses on the range of variables intended due to their small sample size 
(Goldstein et al., 2004). This ensures that the results found are more reliable 
and less likely to be indicative of a type 2 error, further increasing the utility 
of this study both in terms of clinical application and in terms of enhancing a 
sparse evidence base that has been difficult to draw reliable conclusions 
from in the past.   
- 101 - 
Statistical errors are highly common within research studies, with 
reviews suggesting that around 50% of published articles have at least one 
error (Curran-Everett, 2004). The analytical work within this study has been 
thoroughly and competently approached with significant support from 
qualified statisticians. Additionally, statistical software was used to run the 
statistical calculations, further reducing the risk of human error. It is therefore 
hoped that the results discovered are reliable and accurate, however, as 
stated above, there is always a risk of human error in complex work with a 
large database.  
It is advised within neuropsychological research to convert all raw 
score outcomes to standardised scores, such as scaled scores or z scores, 
so that they can be more meaningfully compared within the analysis 
(Crawford, 2003). Where possible scaled scored were used. This meant that 
the FAS and ANT test scores were converted into scaled scores before the 
analysis. Unfortunately, scaled scores were not available for the GNT or the 
HADS. However, scaled scores will hold the same distribution shape (as 
would a z score) as the set of raw scores, as long as the variable is normally 
distributed. As all the variables used in this study were all relatively normally 
distributed this can be considered as less of an issue.  
 
Clinical implications 
Verbal fluency tests are very useful in measuring, monitoring and 
highlighting deficits in verbal communication difficulties and components of 
executive functioning following brain injury/degeneration (Strauss et al., 
2006). More specifically, verbal fluency outcomes play an important role in 
the diagnosis of a number of conditions within the clinical population, such 
as attention deficit/hyperactivity disorder (Andreou & Trott, 2013), 
Alzheimer’s disease (Mathuranath et al., 2010; Monsch et al., 1992; Zhao et 
al., 2013), and Parkinson’s disease (Pettit et al., 2013). Verbal fluency tests 
therefore play a highly instrumental role in neuropsychological assessment 
and diagnosis. This means that advancing the knowledge base in this area 
is important to ensure the provision of accurate and reliable 
neuropsychological assessment and care of patients. 
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Prior to this study there was a notable lack of research in the 
performance of patients with brain tumour (particularly pre-surgery) in 
measures of phonemic and semantic fluency, with the few that were 
available focusing on a wider range of neurocognitive impairments, as 
opposed to focusing more specifically on verbal fluency outcomes 
(Hoffermann et al., 2017; Klein et al., 2001; Miotto et al., 2011; Påhlson, Ek, 
Ahlström, & Smits, 2003; Talacchi et al., 2011; Tucha, Smely, & Lange, 
2001; Tucha et al., 2003). As a result there was little conclusive evidence 
about which factors may influence verbal fluency outcomes, most 
considerably in relation to semantic fluency (Bird et al., 2004; Davis et al., 
2017; Noll et al., 2014). This is the first study to date which has investigated 
the interactions between a comprehensive range of demographic, cognitive, 
tumour and mood factors with verbal fluency outcomes in patients with brain 
tumour.  
These clinically meaningful results have increased some clarification 
of the contradictions in the research base to date. It is also hoped that the 
results will broaden clinicians’ understanding of the impact of these factors 
on verbal fluency, which will support them in making predictions about 
expected performance and tailor interventions accordingly. This study 
strengthens the concept that phonemic fluency is correlated with being 
educated, an increase in semantic memory, and an increase in premorbid 
functioning. Phonemic fluency was also significantly correlated with 
localisation. More specifically, an increase in phonemic fluency is associated 
with tumours in the right frontal and right parietal lobes in comparison to the 
left frontal lobe. This study also supports an association between semantic 
fluency with semantic memory. Knowing the influences created by these 
important factors allows clinicians to be more considerate of variations in 
performance of patients with brain tumour who also align with these 
associative factors. This further enhances the accurate interpretation of 
neurocognitive assessment and diagnostic work and hence the planning of 
appropriate care in patients with brain tumour. Further research in this area, 
particularly with a focus on longitudinal data collection and more precise 
localisation mapping may further enhance the findings in this study. More 
specifically the variables which were unable to show significance possibly 
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due to low power and effect size, as opposed to a clear non-significant 
results with an adequate power outcome should be further investigated 
using studies with more rigorous methodological approaches and enhanced 
power through increased sample size and inclusion of factors this study was 
unable to include as planned (such as tumour size).  
Summary of further research 
Phonemic fluency and gender showed a non-significant correlation, 
however, other papers finding non-significant correlations have been 
combined in a meta-analysis to show significant positive associations 
between these variables. This indicates that greater power could still yield 
significant associations if there is enough power to detect an effect.  
There was also a lack of significant results for semantic fluency and 
depression, which were interestingly supported by a reasonably high level of 
power, inferring the likelihood of a type 2 error was low and therefore the 
results reliable. These results have opposing outcomes to other studies in 
this area and it is hard to explain this result, given the information this study 
holds. It would be interesting to complete a similar study using continuous 
data for depression instead of taking a caseness v non-caseness approach 
and see how these results compare to those found in the studies showing 
relationships between these variables. 
There was a lack of significant results for analyses looking at anxiety 
and each form of fluency. These results support the limited number of 
previous studies analysing similar variables (Airaksinen et al., 2005; Talacchi 
et al., 2011; Yochim et al., 2013) and so could be assumed to be an 
accurate representation of the relationship. However, as has been discussed 
above, some variables have shown non-significant associations in individual 
studies, but then highlighted significant associations when combined in a 
meta-analysis. As the results for both types of fluency in this study lacked 
power, indicating the possible presence of a type 2 error, these results may 
be similarly worth following up with a meta-analysis and/or a study with 
higher levels of power.   
This study had aimed to look in more detail at tumour factors, 
including size and a greater range of tumour types than was achieved. Due 
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to the need to reduce the number of variables in the analysis to attempt to 
maintain some power this study was only able to look for results between 
glioma and meningioma, which were insignificant, but which also lacked 
power. This is unfortunate as there is such a sparsity of research in the area 
of tumour type and verbal fluency that being able to fill this gap in the 
evidence base could have been very valuable. Additionally there was an 
unexpected lack of data for tumour size which did not pass the MCAR test of 
distribution of missing data and so needed to be dropped from the analysis. 
Previous research has indicated that an increase in tumour size is likely to 
have a greater association with performance deficits (Kayl & Meyers, 2003). 
Further research utilising similar methods to this study with a greater number 
of participants in both these areas would be beneficial to filling these gaps in 
the evidence base and further informing clinical practice. 
While there were some significant results for localisation effects in 
phonemic fluency they needed to be interpreted with caution due to the very 
variable distribution of data among the localisation categories (meaning a 
number of the localisations had very low participant numbers). The areas 
where significant results were not found all had seven or less participant 
data sets assigned to them in the analysis of localisation of phonemic 
fluency. This naturally brings to question the reliability of these results when 
interpreted as a whole ‘localisation effect’ as there is clearly differences 
among the localisation groups in how replicable and representative the 
outcomes in the groups with a small sample size are. Further research in 
this area where it is possible to collect a more even distribution of data 
among the localisation areas of interest would help clarify the outcomes 
found in this study. More importantly, this study was unable to analyse the 
more specific localisations of interest (e.g. left dorsolateral frontal lobe) due 
to this data not being available from the service. Being able to focus an 
analysis to this level of specificity would be likely to yield more reliable and 
clinically meaningful results because the broader the area considered, the 
greater the likelihood of inclusion of data that is not related to the neural 
areas relevant to the skills being assessed. Similarly, the more specific the 
associations found in studies like these, the more helpful the results will be 
for clinicians supporting patients with brain tumour as they can consider with 
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more certainty the influence of the patient’s tumour localisation on the skill of 
interest.  
A number of methodological design flaws related to the assumptions 
of modularity theory and the use of lesion-behaviour mapping have been 
discussed above. The results of this study could be further validated by 
collaborating with studies in this area using neurologically healthy 
participants and forms of activation monitoring (such as fMRI scanning), 
most specifically to allow monitoring of timing information on the stages of 
process and the roles of feedback within verbal fluency performance 
(Rorden & Karnath, 2004). 
Summary and conclusion 
Verbal fluency tests are very useful in measuring, monitoring and 
highlighting deficits in verbal communication difficulties and components of 
executive functioning following brain injury/degeneration (Strauss et al., 
2006). More specifically they play a highly instrumental role in 
neuropsychological assessment and diagnosis of patients with a range of 
neurological conditions (Andreou & Trott, 2013; Mathuranath et al., 2010; 
Monsch et al., 1992; Pettit et al., 2013; Zhao et al., 2013).  
This study correctly hypothesised that having a tumour in the left 
frontal lobe, being male, not having acquired exams during education, being 
depressed, having poor semantic memory, and having poor premorbid 
functioning are good predictors of phonemic fluency outcomes in patients 
with brain tumours. Knowing the influences created by these important 
factors will allow clinicians to be more considerate of variations in 
performance of patients with brain tumour who also align with these 
associative factors. This further enhances the accurate interpretation of 
neurocognitive assessment and diagnostic work and hence the planning of 
appropriate care in patients with brain tumour. Further research in this area, 
particularly with a focus on longitudinal data collection using methods that 
add to the lesion-behaviour mapping models applied here, such as using 
neurologically healthy participants with scanning techniques (such as fMRI) 
and more precise localisation mapping, may enhance the findings in this 
study. 
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Our hypotheses around the factors that influence semantic fluency 
were not supported. More specifically, localisation, semantic memory, 
depression and education did not predict semantic fluency. Semantic 
memory is a good predictor for semantic fluency, and was the only 
significant predictor found in this study for semantic fluency. Suggestions 
have been discussed that may support an increased likelihood of detecting 
significant effects in future analyses of factors influencing semantic fluency, 
such as the importance of ensuring an adequate sample of participants with 
higher levels of depression, accounting for age effects, tumour size effects, 
being able to focus on more precise localisations, and ensuring more 
adequate distribution of participants across these localisations. 
These results have increased some clarification of the contradictions 
in the research base to date, but there are still areas where further 
information is required to better make sense of the outcomes. It is hoped 
that these results will broaden and strengthen clinicians’ understanding of 
the impact of some of the factors highlighted here to play a role in verbal 
fluency performance. This should hopefully support them in making 
predictions about expected performance and tailor interventions accordingly, 
particularly for patients with tumours in the left frontal lobe. This study has 
also served to further highlight some of the requirements for more research 
in this complex topic area which is clearly lacking clarity and support from 
the current evidence base. 
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Appendix A: Table illustrating the initial higher order categories 
for localisation 
Original label Category 1  
(18 
categories) 
Category 2  
(10 
categories) 
Category 3  
(2 
categories) 
Anterior Fossa                             x Frontal x 
Anterior third ventricle                  Intraventricular Intraventricular x 
Diffuse                                   Other Other x 
Fourth ventricle                          Intraventricular Intraventricular x 
Frontal lobe                               x Frontal x 
Intraventricular                          Intraventricular Intraventricular x 
Left and right frontal                     x Frontal x 
Left anterior cranial 
fossa                
Left anterior Left anterior Left 
Left anterior fossa                        Left anterior Left anterior Left 
Left basal frontal                         Left frontal Left frontal Left 
Left cerebellar                            Subcortical Subcortical Left 
Left cerebellopontine 
angle Cistern       
Subcortical Subcortical Left 
Left frontal                           Left frontal Left frontal Left 
Left frontal                     Left frontal Left frontal Left 
Left frontal convexity                     Left frontal Left frontal Left 
Left frontal lobe                         Left frontal Left frontal Left 
Left frontal medial                       Left frontal 
medial 
Left frontal Left 
Left frontoparietal                        Left fronto 
parietal 
Left frontal Left 
Left frontoparietal lobe                  Left fronto 
parietal 
Left frontal Left 
Left fronto-temporal                      Left fronto 
temporal 
Left frontal Left 
Left lateral ventricle                    Intraventricular Intraventricular Left 
Left occipital, 
parafalcine                
Left occipital Left occipital Left 
Left parafalcine, Faulx                    x x Left 
Left parietal                             Left parietal Left parietal Left 
Left parieto-occipital                    Left parieto 
occipital 
Left parietal Left 
Left parieto-temporal                     Left parieto 
temporal 
Left parietal Left 
Left posterior frontal                    Left frontal Left frontal Left 
Left posterior frontal                     Left frontal Left frontal Left 
Left posterior parietal 
parafalcine        
Left parietal Left parietal Left 
Left posterior temporal                   Left temporal Left temporal Left 
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Left spenoid wing                          x x Left 
Left sphenoid wing                         x x Left 
Left temporal                             Left temporal Left temporal Left 
Left temporal                              Left temporal Left temporal Left 
Left temporal lobe                        Left temporal Left temporal Left 
Medial anterior right 
frontal lobe         
Right frontal 
medial 
Right frontal Right 
Parasaggital frontal                       x Frontal x 
Parieto-occipital                         x x x 
 
Pituitary                                 
Subcortical Subcortical x 
Posterior fossa                            Subcortical Subcortical x 
Posterior left petrous 
temporal bone       
x x Left 
Right                                     x x Right 
Right frontal                             Right frontal Right frontal Right 
Right frontal parafalcine 
region          
Right frontal Right frontal Right 
Right fronto-parietal                     Right
frontoparietal 
Right frontal Right 
Right fronto-temporal                     Right 
frontotemporal 
Right frontal Right 
Right hemisphere                          x x Right 
Right parietal                            Right parietal Right parietal Right 
Right parietal                             Right parietal Right parietal Right 
Right posterior fossa                     Right posterior x Right 
Right posterior 
Temporal/parietal          
Right posterior x Right 
Sphenoid wing                              x x x 
Sub frontal                                x Frontal x 
Subcortical                               Subcortical Subcortical x 
Tentorial hiatus                           Subcortical Subcortical x 
Third ventricle                           Intraventricular Intraventricular x 
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Appendix B: Table illustrating secondary higher order categories 
for localisation 
Original label Category 4  
(7 categories) 
Category 5 
(6 categories) 
Anterior Fossa                             Frontal Frontal 
Anterior third ventricle                  Other X 
Diffuse                                   Other X 
Fourth ventricle                          Other X 
Frontal lobe                               Frontal Frontal 
Intraventricular                          Other X 
Left and right frontal                     Frontal Frontal 
Left anterior cranial fossa                Other X 
Left anterior fossa                        Other X 
Left basal frontal                         Left frontal Left frontal 
Left cerebellar                            Other X 
Left cerebellopontine angle 
Cistern       
Other X 
Left frontal                           Left frontal Left frontal 
Left frontal                     Left frontal Left frontal 
Left frontal convexity                     Left frontal Left frontal 
Left frontal lobe                         Left frontal Left frontal 
Left frontal medial                       Left frontal Left frontal 
Left frontoparietal                        Left frontal Left frontal 
Left frontoparietal lobe                  Left frontal Left frontal 
Left fronto-temporal                      Left frontal Left frontal 
Left lateral ventricle                    Other X 
Left occipital, parafalcine                Other X 
Left parafalcine, Faulx                    Other X 
Left parietal                             Left parietal Left parietal 
Left parieto-occipital                    Left parietal Left parietal 
Left parieto-temporal                     Left parietal Left parietal 
Left posterior frontal                    Left frontal Left frontal 
Left posterior frontal                     Left frontal Left frontal 
Left posterior parietal 
parafalcine        
Left parietal Left parietal 
Left posterior temporal                   Left temporal Left temporal 
Left spenoid wing                          Other X 
Left sphenoid wing                         Other X 
Left temporal                             Left temporal Left temporal 
Left temporal                              Left temporal Left temporal 
Left temporal lobe                        Left temporal Left temporal 
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Medial anterior right frontal 
lobe         
Right frontal Right frontal 
Parasaggital frontal                       Frontal Frontal 
Parieto-occipital                         Other X 
 
Pituitary                                 
Other X 
Posterior fossa                            Other X 
Posterior left petrous temporal 
bone       
Other X 
Right                                     Other X 
Right frontal                             Right frontal Right frontal 
Right frontal parafalcine region          Right frontal Right frontal 
Right fronto-parietal                     Right frontal Right frontal 
Right fronto-temporal                     Right frontal Right frontal 
Right hemisphere                          Other X 
Right parietal                            Right parietal Right parietal 
Right parietal                             Right parietal Right parietal 
Right posterior fossa                     Other X 
Right posterior 
Temporal/parietal          
Other X 
Sphenoid wing                              Other X 
Sub frontal                                Frontal Frontal 
Subcortical                               Other X 
Tentorial hiatus                           Other X 
Third ventricle                           Other X 
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Appendix C: Table illustrating higher order categories for tumour 
type 
Original label Category 1 (5 
categories) 
Category 2 (2 
categories) 
Astrocytoma                                Glioma Glioma 
Colloid cyst                               Cystic Removed 
Cystic                                     Cystic Removed 
Ependymoma                                 Glioma Glioma 
Glioblastoma                               Glioma Glioma 
Glioma                                     Glioma Glioma 
Glioma/meningioma                          Mixed X 
Meningioma                                 Meningioma Meningioma 
Mesenchymal chondrosarcoma                 Other X 
Metastatic                                 Other X 
Neurocytoma                                Other X 
Neuroma                                    Other X 
Non-specific                               Other X 
Oligodendroglioma                          Glioma Glioma 
Other/unknown                              Other X 
Pituitary                                  Other X 
Porencepahlic cyst                         Cystic Removed 
Subependymoma                              Glioma Glioma 
Vestibular schwannoma                      Other X 
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Appendix D: Table illustrating breakdown of frequency 
data for HADS-D 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid .0 6 4.9 4.9 4.9 
1.0 11 8.9 8.9 13.8 
2.0 13 10.6 10.6 24.4 
3.0 10 8.1 8.1 32.5 
4.0 8 6.5 6.5 39.0 
5.0 7 5.7 5.7 44.7 
6.0 11 8.9 8.9 53.7 
7.0 14 11.4 11.4 65.0 
8.0 11 8.9 8.9 74.0 
9.0 7 5.7 5.7 79.7 
10.0 7 5.7 5.7 85.4 
11.0 5 4.1 4.1 89.4 
12.0 4 3.3 3.3 92.7 
13.0 5 4.1 4.1 96.7 
14.0 1 .8 .8 97.6 
15.0 1 .8 .8 98.4 
17.0 1 .8 .8 99.2 
20.0 1 .8 .8 100.0 
Total 123 100.0 100.0  
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Appendix E: Table illustrating breakdown of frequency 
data for HADS-A 
 Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid .0 1 .8 .8 .8 
1.0 2 1.6 1.6 2.4 
2.0 5 4.1 4.1 6.5 
3.0 6 4.9 4.9 11.4 
4.0 8 6.5 6.5 17.9 
5.0 9 7.3 7.3 25.2 
6.0 12 9.8 9.8 35.0 
7.0 10 8.1 8.1 43.1 
8.0 14 11.4 11.4 54.5 
9.0 7 5.7 5.7 60.2 
10.0 9 7.3 7.3 67.5 
11.0 7 5.7 5.7 73.2 
12.0 8 6.5 6.5 79.7 
13.0 6 4.9 4.9 84.6 
14.0 5 4.1 4.1 88.6 
15.0 4 3.3 3.3 91.9 
16.0 5 4.1 4.1 95.9 
17.0 2 1.6 1.6 97.6 
19.0 2 1.6 1.6 99.2 
20.0 1 .8 .8 100.0 
Total 123 100.0 100.0  
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Appendix Fi: Correlations matrix for FAS data 
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T
e
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R
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ro
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ta
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R
ig
h
t 
P
a
rie
ta
l 
FAS 1.00 .036 -.158 -.195* -.186* .273** .188* 
Frontal .036 1.000 -.252* -.059 -.080 -.144 -.074 
 Left Frontal -.158 -.252* 1.000 -.224* -
.302** 
-
.544** 
-
.278** 
 Left Parietal -.195* -.059 -.224* 1.000 -.071 -.128 -.065 
 Left 
Temporal 
-.186* -.080 -
.302** 
-.071 1.000 -.173 -.088 
 Right 
Frontal 
.273** -.144 -
.544** 
-.128 -.173 1.000 -.159 
 Right 
Parietal 
.188* -.074 -
.278** 
-.065 -.088 -.159 1.000 
TOPF .436** .042 .191* -.221* -.238* .053 -.049 
GNT .377** .175 .070 -.127 -.227* .068 -.055 
HADS-D -.246* .007 .097 -.065 .026 -.082 -.032 
Gender .085 -.071 .152 .098 -.068 -.013 -.212* 
 Education .338** .050 .012 -.108 -.194* .095 .076 
Tumour Type .170 -.134 -.140 -.119 .272** .069 .084 
 
* p < .05; **p < .01 
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Appendix Fii: Correlations matrix for FAS data 
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FAS .436** .377*
* 
-.246* .085 .338** .170 
Frontal .042 .175 .007 -.071 .050 -.134 
 Left 
Frontal 
.191* .070 .097 .152 .012 -.140 
 Left 
Parietal 
-.221* -.127 -.065 .098 -.108 -.119 
 Left 
Temporal 
-.238* -
.227* 
.026 -.068 -.194* .272** 
 Right 
Frontal 
.053 .068 -.082 -.013 .095 .069 
 Right 
Parietal 
-.049 -.055 -.032 -.212* .076 .084 
TOPF 1.00 .450*
* 
-.145 .117 .198* .109 
GNT .450** 1.00 -.051 -.191* .138 .063 
HADS-D -.145 -.051 1.000 .120 .052 -.162 
Gender .117 -
.191* 
.120 1.000 .075 -.315** 
 
Education 
.198* .138 .052 .075 1.000 .127 
Tumour 
Type 
.109 .063 -.162 -
.315** 
.127 1.000 
 
* p < .05; **p < .01 
 
 
